UNLV Retrospective Theses & Dissertations
1-1-2000

The effects of Bios Life and exercise on total cholesterol, serum
low-density lipoprotein, and high-density lipoproteins
Lori Jan Inderlied-Rucks
University of Nevada, Las Vegas

Follow this and additional works at: https://digitalscholarship.unlv.edu/rtds

Repository Citation
Inderlied-Rucks, Lori Jan, "The effects of Bios Life and exercise on total cholesterol, serum low-density
lipoprotein, and high-density lipoproteins" (2000). UNLV Retrospective Theses & Dissertations. 1207.
http://dx.doi.org/10.25669/wkee-r66y

This Thesis is protected by copyright and/or related rights. It has been brought to you by Digital Scholarship@UNLV
with permission from the rights-holder(s). You are free to use this Thesis in any way that is permitted by the
copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from
the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/
or on the work itself.
This Thesis has been accepted for inclusion in UNLV Retrospective Theses & Dissertations by an authorized
administrator of Digital Scholarship@UNLV. For more information, please contact digitalscholarship@unlv.edu.

INFORMATION TO USERS

This manuscript has been reproduced from the microfilm master. UMI films
the text directly from the original or copy submitted. Thus, some thesis and
dissertation copies are in typewriter face, while others may be from any type of
computer printer.
The quality of this reproduction is dependent upon th e quality of the
co py subm itted. Broken or indistinct print, colored or poor quality illustrations
and photographs, print bleedthrough, substandard margins, and improper
alignment can adversely affect reproduction.
In the unlikely event that the author did not send UMI a complete manuscript
and there are missing pages, these will be noted.

Also, if unauthorized

copyright material had to be removed, a note will indicate the deletion.
Oversize materials (e.g., maps, drawings, charts) are reproduced by
sectioning the original, beginning at the upper left-hand comer and continuing
from left to right in equal sections with small overlaps.
Photographs included in the original manuscript have t)een reproduced
xerographically in this copy.

Higher quality 6” x 9” black and white

photographic prints are available for any photographs or illustrations appearing
in this copy for an additional charge. Contact UMI directly to order.

Bell & Howell Information and Learning
300 North Zeeb Road, Ann Aitwr, Ml 48106-1346 USA
800-521-0600

UMI*
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

THE EFFECTS OF BIOSLIFE AND EXERCISE ON TOTAL
CHOLESTEROL, SERUM LOW DENSITY LIPOPROTEIN,
AND HIGH DENSITY LIPOPROTEINS

by

Lori Jan Inderlied-Rucks
Bachelor o f Arts
University of Pittsburgh
1996

A thesis submitted in partial fuhilhnent
o f the requirements for the

M aster o f Science in Exercise Physiology
D epartm ent of Kinesiology
College of Health Sciences

G raduate College
University o f Nevada, Las Vegas
August 2000

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

UMI Number: 1403080

Copyright 2000 by
Inderlied-Rucks, Lori Ja n
All rights reserved.

UMI
UMI Microform 1403080
Copyright 2001 by Bell & Howell Information and Learning Com pany.
All rights reserv ed . This microform edition is protected against
unauthorized copying under Title 17, United S ta te s C ode.

Bell & Howell Information and Learning C om pany
300 North Zeeb Road
P.O. Box 1346
Ann Arbor, Ml 48106-1346

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Copyright by Lori Jan Inderlied-Rucks 2000
All Rights Reserved

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

UNTV

T hesis Approval
The Graduate College
University of Nevada, Las Vegas

June 22

^ 2 0 00

The Thesis prepared by
Lori Jan Inderlied-Rucks
Entitled
The effects of BiosLife and Exercise on Total Cholesterol, Serum
Low Density Lipoprotein, and High Density Lipoproteins___________

is approved in partial fulfillment of the requirements for the degree of
_________________ M a s te r o f S c ie n c e i n E x e r c i s e P h y s i o l o g y

I i

Examination Committee Chair

Dean o f the Graduate College

nation Comrrmtée

mination Com mittee M ember

Graduate College Factnty Representative

P R /1017-53/1-00

11

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

ABSTRACT
The Effects o f Bios Life and Exercise on Total Cholesterol, Serum Low Density
Lipoprotein, and High Density Lipoprotein
by
Lori Jan Inderlied-Rucks
Lawrence A. Golding, PhJD. Examination Committee Chair, Distinguished Professor o f
Kinesiology, University o f Nevada, Las Vegas
The present study was designed to determine the effects o f Bios Life, a non
prescription dietary fiber supplement, on serum lipoproteins and determine whether
exercise accentuates this effect. Fifty male and female subjects (ages 30-60) participated
in the study. Twenty-five subjects were exercising regularly in a supervised exercise
program and the other twenty-five were sedentary. All participants where required to
have a LDL-C o f 130 mg/dl or higher and none were on any cholesterol lowering
medications. Blood was drawn three times at baseline, before the study started, 45 days
into the program and at 90 days which was the end o f the study. Total cholesterol, HDL
and LDL’s were analyzed by the Cholestech L.D.X. system. A mixed model ANOVA
was used to analyze the data. The results indicated significant decreases in total
cholesterol from baseline to 45 to 90 days (F = 18.29, p<0.05) with no significant
difference between exercise and non-exercise groups (F = 0.20, p>0.05). The results also
indicated significant decreases in LDL’s from baseline to 45 to 90 days (F = 21.60,
p<0.05) with no significant difference between exercise and non-exercise groups (F =

iii
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1.59, p>0.05). The analysis o f the HDL’s yielded no significant difference between
exercise and non-exercise groups (F = 1.07, p>0.05) n o r was there a significant
difference from baseline to 45 to 90 days (F = 1.67, p>0).05). These results suggest that
whether or not one participates in an exercise program B ios Life will decrease total
cholesterol and LDL’s equally without c hangin g HDL’s , which may help reduce the risk
o f coronary heart disease.
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CHAPTER 1

INTRODUCTION
Coronary heart disease (CHD) is the leading cause o f death in the United States.
The American Heart Association (AHA) statistics show that in 1993 there were 489,970
deaths from CHD. In 1998, as many as 1,500,000 Americans had a new or recurrent
heart attack and about one third died. In 1993 artherosclerosis was the underlying cause
o f many o f the 639,710 heart attack and stroke deaths. In the U.S. approximately 96
million adults have total blood cholesterol levels o f over 200mg/dl and 37.8 million have
levels greater than 240 mg/dl according to the AHA. These high levels are a major
contributor to artherosclerosis and other types o f coronary artery disease. Due to its
lifestyle etiology, CHD is expected to remain the leading cause o f death for future years.
These statistics prove that CHD is a major public health problem and concern (Anderson,
Zettwach, Feldman, Clark, Oeltgen & Bishop, 1988).
It has been well documented that both high levels o f total serum cholesterol and
specifically low-denshy lipoproteins (LDL-C cholesterol) are linked with coronary heart
disease (Bridges, Anderson, Deakins, Dillon & Wood, 1992). From the epidemiological
data from the Fram in gh am Heart Study elevated total serum cholesterol was determined
to be a major coronary risk factor. Larosa and associates (1990) studied 2,282 men and
2,845 women investigating CHD history and total cholesterol levels and concluded that
there was definite evidence that high levels o f total cholesterol were associated with a
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high incidence o f CHD and that low levels o f total cholesterol were associated with a low
incidence o f CHD (Larosa, Becker & Fitzgerald, 1990).
The National Cholesterol Education Program (Expert Panel, 1993) recommends
the following values for cholesterol in individuals to be:
Total Cholesterol

< 200mg/dl

HDL

> 35mg/dl

LDL

< 130mg/dl

Individuals with 200-239 mg/dl are considered borderline risk and those with total
cholesterol greater than 240 are at abnormal risk. Increasing HDL and decreasing LDL
reduces the risk o f CHD (Anderson, Riddell-Mason, Gustafson, Smith & Mackey, 1992).
A lowfat diet was initially the main method o f reducing total cholesterol. New
cholesterol lowering drugs are now commonly prescribed. Cholesterol lowering drugs
were classified into bUe acids, sequestrates, nicotinic acids, statins, fibric acids and
probucol (Anderson et al., 1988). The goals o f drug therapy was to lower total
cholesterol, raise HDL’s and lower LDL’s. However, there were several major side
effects. The side effects can range from itching o f the skin, gastrointestinal distress, liver
toxic effects, and muscular damage due to interaction between drugs and blood clots
(JAMA, 1993).
Dietary therapy remains the first choice for treatment o f high cholesterol. There
is evidence indicating that dietary fiber has important lipid lowering effects and may
reduce risk o f CHD (Bell, Hectom, Reynolds & Hunninghake, 1990). Increasing Dietary
fiber intake is an important therapeutic treatment for other specific conditions besides
CHD such as diabetes, hyperlipidemia, hyperglyceridemia, hypercholesterolemia and
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intestinal disorders (Anderson, Gilinsky, Deakins, Smith, O’Neal, Dillion & Oeltgen,
1991). Individuals consuming a diet high in fiber tend to have lower incidence o f
myocardial infarction and sudden cardiac death (HaskeU, Spiller, Jensen, Ellis & Gates,
1992).
Dietary fiber is defined as “the endogenous components o f plant materials in the
diet that are resistant to digestion by enzymes produced by man” (Anderson, 1987).
There are two main types o f fibers soluble and insoluble. In experimental studies, soluble
fiber has been shown to reduce blood cholesterol levels. Soluble fiber increases the fecal
excretion o f bUe acids, which may alter the quantity o f cholesterol absorbed by the
intestine. The fibers fi’om fi’esh fimits, vegetables, legumes, oat bran and barley appear to
have the most significance for reducing cholesterol levels (Haskell et al., 1992).
Insoluble fiber, such as, wheat bran have essentially no effect on serum cholesterol levels.
The general purpose o f dietary fiber as therapy is to reduce elevated serum
cholesterol levels. This is achieved primarily by reducing fat intake and consuming a
healthy diet, rich in fiber. Dietary therapy in conjunction with regular exercise is
considered an essential element in therapy o f elevated serum cholesterol (Ready, 1996).
Exercise has been shown to help in the promotion o f weight reduction which enhances
LDL cholesterol lowering, reducing triglyceride, raising HDL, reduces blood pressure
and decreasing the risk for diabetes mellitus (Grundy, 1986). Therefore, the combination
o f regular exercise and diet rich in fiber should lower total cholesterol, increase HDL,
decrease LDL and consequently reduce the risk o f CHD.
The purpose o f this study was to investigate the effects o f Bios Life, a non
prescription dietary fiber supplement, on Total, LDL cholesterol and determine whether
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exercise accentuates this effect. The null hypothesis is that exercise does not accentuate
the effect o f Bios Life on Total Cholesterol, Low-Density Lipoproteins and High-Density
Lipoproteins and the alternate hypothesis is that exercise accentuates the effect o f Bios
Life on Total Cholesterol, Low-Density Lipoproteins and High-Density Lipoproteins.
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CH A PTER !

LITERATURE REVIEW
An adult male weighing 70kg would have approximately 140g o f cholesterol
present in the body with 8 g o f this in the plasma (Sabrine, 1977). The average synthesis
of cholesterol in the body is about lOOOmg per day. The daily production is
approximately 400mg from intestinal absorption and 600mg synthesized in the cells and
the liver. An adult consuming a normal American diet ingests about lOOOmg per day.
Every cell o f the body, except a mature red blood ceU, produces cholesterol (Sabrine,
1977). The liver is a major organ in cholesterol synthesis. The liver must synthesize and
maintain control over the enzymes that convert acetyl coenzyme A to cholesterol. More
than ninety percent o f the cholesterol in the body is found in the cell membrane.
Chemical Nature o f Cholesterol
At the end o f the eighteenth century a French chemist de Fourcroy described the
compound now known as cholesterol by isolating a crystalline substance from the
alcohol-soluble fraction o f human gallstones (Sabrine, 1977). About the same time
another French chemist Chevreue detected it in human and animal bile (Sabrine, 1977).
After the turn o f the century another French chemist Lecanu found cholesterol in the
blood o f humans (Sabrine, 1977). De Fourcroy’s gave the name cholesterine from the
Greek words Chole meaning bile and Steros meaning solid (Sabrine, 1977). The correct
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empirical formula (C2 7 H 4 6 O) was published in 1888 by Reinitzer (Newsholme & Leech,
1983).
Cholesterol is probably the best known sterol, which is essential to the human
body. “Cholesterol is found associated with the fets, but chemically it is not related to
them. Cholesterol, a white waxy solid, is the principal sterol found in animal organisms”
(Smolin & Grosvenor, 1997). Most o f the cholesterol found in the body occurs in free
form, the unesterifred alcohol, which is precipitable by digitonin. The so-called bound
cholesterol is found in much smaller portions; it is present as the ester o f long chain fatty
acids. The largest amount o f cholesterol is found in muscle, nervous and connective
tissue. It is needed to synthesize vitamin D, cholic acid which is part o f bile, some
hormones, and cortisol which promotes glucose synthesis in the liver (Smolin &
Grosvenor, 1997).
Production, Absorption, Transportation and Excretion
Cholesterol is not soluble in water therefore it can not enter the blood stream
directly. Lipoproteins called chylomicron are formed to help cholesterol enter the blood
stream (Williams, 1997). Chylomicrons are formed by combining triglycerides with
cholesterol, free fatty acids, phospholipids, traces o f fat soluble vitamins, steroid
hormones and lipoproteins (Williams, 1997). Once chylomicrons are produced they will
carry lipids from the intestines and deliver triglycerides to body cells. On the surface o f
cells, lining the blood vessels is lipoprotein lipase which breaks down the triglycerides
too fetty acids which can be either used as fiiel or resynthesized into triglycerides for
storage. After the breakdown o f chylomicron cholesterol and protein remain and
returned to the liver (Smolin & Grosvenor, 1997).
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Crystalline cholesterol administered orally is absorbed in only small amounts
unless some fatty material is also present in the intestine. This is not true with colloidal
or amorphous cholesterol, which can be absorbed in the absence o f dietary fat. Bile and
pancreatic juices are said to be two agents, which aid in the absorption o f cholesterol,
because the combination o f cholesterol with bile acids increase the solubility o f
cholesterol in intestinal fluids. Pancreatic and intestinal enzymes hydrolyze cholesterol
esters, which are later re-synthesized before reaching the lymph stream, the main route by
which cholesterol is absorbed. Some cholesterol is absorbed directly into the blood
stream; part o f the absorbed free cholesterol, but not the ester, is excreted in the bile; part
is changed to coprosterol and eliminated later in the feces (Smolin & Grosvenor, 1997).
Lipids are produced in the liver, by breaking down excess protein, carbohydrate
or alcohol to produce either triglycerides or cholesterol. In the liver triglycerides,
cholesterol, fatty acids and returned chylomicron are formed into very-low-density
lipoprotein (VLDL) (Smolin & Grosvenor, 1997). VLDL carries a large lipid content,
but also contains about ten to fifteen percent cholesterol formed in the liver from
endogenous fat stores (Williams, 1997). VLDL transport lipids out o f the liver and
delivers triglycerides to body cells. They must be broken-down by the enzyme
lipoprotein lipase so that fatty acids can be taken up by the cells (Smolin & Grosvenor,
1997).
Triglycerides are removed from VLDL leaving a smaller intermediate density
lipoprotein (DDL) which contains mostly cholesterol. These IDL’s are either transported
to the liver or formed into low-density lipoproteins (LDL’s). LDL’s are lipoproteins that
transport cholesterol to cells. For LDL’s to be taken up by the cells, apoliprotein B, must
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bind with the LDL receptor. A LDL receptor is a protein on the surface o f all cells,
which binds to LDL particles and allows their contents to be taken up for uses by the cell
(Smolin & Grosvenor, 1997).
The body can not breakdown cholesterol esters, so it must be transported back to
the liver where then it will be eliminated from the body as bile. This process is done by
high-density lipoprotein (HDL). HDL’s are manufactured in the intestinal tract. They
are then transported through blood to pick up cholesterol from cells so that the body can
excrete it (Smolin & Grosvenor, 1997).
Metabolism
The synthetic process o f cholesterol takes place in the liver and may occur in
other organs. In all tissues except in the brain, cholesterol is continually regenerated. I f
any organ can be singled out as the single most important to metabolize cholesterol and
some amount o f plant sterols, it is the hver. It can both synthesize and destroy
cholesterol. The breakdown and lose o f cholesterol can occur in four ways:
1. By direct reduction to dihydrocholesterol or by passage through the
intermediate cholesterone to dihydrocholesterol or coprosterol.
2. By loss o f cholesterol in the feces.
3. By conversion into steroid hormones.
4. By conversion to bile acids in the liver.
Cholesterol and Age
There are a number o f variables that are important in determining or changing the
level of blood cholesterol in the body. Throughout the day the level o f serum cholesterol
remains for the most part constant, even though there is a large variation in the rate that

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

9
cholesterol enters and leaves the body (Winkel, Stratland & Bokelund, 1974). Over an
extended period o f time the amount o f exdogensis cholesterol entering the body
compared to cholesterol degradation will rise significantly (Hollister & Wright, 1956).
This significant rise will eventually reach abnormal level o f cholesterol (Hollister &
Wright, 1956).
Females at birth have slightly higher levels o f plasma cholesterol than males.
During childhood, adolescence and early adulthood there is very little difference in blood
cholesterol between men and women (Syerberg & Hjome, 1973). In later life males tend
to have higher serum cholesterol levels due to higher concentrations o f VLDL and LDL.
Serum cholesterol levels tend to be lower in premenstrual women. After the age o f 50
male cholesterol levels tend to lower as females tend to raise slightly (Adlersberg,
Schaefer, Steinberg & Wang, 1956). This rise in serum cholesterol levels in women is
due to the fact that women going through menopause have lower levels o f estrogen.
Estrogen is a cholesterol-lowering agent and the decrease o f estrogen during menopause
is the cause o f rising serum cholesterol levels in women.
At birth plasma levels o f cholesterol are usually low around 80mg/dl (Darmady,
Fosbrooke & Llyod, 1972). Glueck, Heckman, Schoenfeld, Steiner and Pearce, (1971)
studied the umbilical cord blood cholesterol in 1800 consecutive unselected live births
and found it to be about 80mg/100 ml. After birth cholesterol rises rapidly to around 183
mg/100ml for the average male 20 to 29 years o f age depending mostly on diet
(Fredrickson, Levy & Lees, 1967). Throughout life, cholesterol levels continue to rise
slowly (Darmady, Fosbrooke & Lloyd, 1972). At about 50 years o f age serum
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cholesterol levels begin to plateau off. In men the level begins to drop slightly and in
women blood cholesterol may continue to rise after 50 (Fredrick, Levy & Lees, 1967).
Adlerberg and associates (1956) studied approximately 1,200 healthy males and
females between the age o f 2 and 77 years. Their blood serum was analyzed fijr
cholesterol in order to establish average lipid levels. It was found that in the age groups
3-12 and 53-57, the females have significantly higher cholesterol levels than men,
whereas, in age groups 28-42 males have significantly higher levels than women.
Adlersberg also compared the serum cholesterol levels between males and females at
different age groups. The total serum cholesterol level of the males remained constant
fi-om age 2 throughout 19. From the age 20 to 33 there was a significant increase o f total
cholesterol level. No change was seen imtil after age 60. The total serum cholesterol
level o f the females did not change significantly from age 2 through 32. From age 33 to
58 a significant increase o f 3.2 mg per lOOcc per year was seen. The difference in the
serum cholesterol levels at the different age-trends between males and females may be
the result from evidence showing that males at a young age start to show signs o f
coronary artery disease and among women they tend to show signs o f coronary artery
disease after the age o f 50 around the time o f menopause (Adlersberg, Schaefer,
Steinberg & Wang, 1956).
Diurnal and Seasonal Variations
Several studies have examined seasonal fluctuations o f serum cholesterol in man.
Fyfe, Dunnigan, Hamilton and Rae (1968) studied the seasonal variation o f 5,630 serum
cholesterol and serum triglyceride on patients with confirmed or suspected ischemic heart
disease. Serum cholesterol levels were at their peak in the spring, and fell progressively
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to the lowest level in autumn. Serum Triglyceride did not exhibit this kind o f seasonal
fluctuation. This study concluded that the highest level o f serum cholesterol occur in the
spring and the lowest in the autumn (Fyfe et al., 1968).
Cholesterol and Heart Disease
Atherosclerosis is the major disease affecting the heart and blood vessels, and is
the leading cause o f death in the United States (Bierman & Chait, 1988). According to
the International Atherosclerosis Project; observations were made on 19 different
countries and race groups concluding that “practically aU persons have some degree o f
atherosclerosis when examined at autopsy” (McHill, 1968). Atherosclerosis is a
progressive disease throughout life. The severity which it develops seems to be due
primarily to environmental conditions (Gresham, 1972). Since the 1960’s the number o f
deaths from coronary artery disease has been declining at a fast rate but stül nearly h alf o f
the deaths in this country are from blood vessel diseases (Lipid Research Clinics
Program, 1984).
Atherosclerosis is the result o f fatty cholesterol deposits in blood vessel walls;
reducing elasticity and eventually blocking blood flow (Smolin & Grosvenor, 1997). It is
a disorder o f the coronary arteries, cerebral arteries, iliac and femoral arteries and aorta
that is responsible for coronary heart disease, stroke and peripheral arterial disease
(Bierman & Chait, 1988). Atherosclerosis is characterized by the collection o f lipids in
smooth muscle cells, macrophages o f the inner lining o f the walls o f arteries (Bierman &
Chait, 1988).
In 1833 Lobstein introduced the word atherosclerosis, athero meaning gruel or
musk and scleroses meaning hardening o f the arteries (Katz & Stamler, 1953). Michael
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Brown and Joseph Goldstein showed the connection between the discovery o f LDL
receptors on cells with the development o f atherosclerosis (Smolin & Grosvenor, 1997).
LDL receptors bind to LDL particles and help them to be absorbed by the cell. A high
level o f LDL means there is too much cholesterol or not enough LDL receptors cells, this
leads to cholesterol deposits in the artery walls causing atherosclerosis (Smolin &
Grosvenor, 1997).
Even though extensive studies have been done on atherosclerosis, there is stdl no
known cause o f the exact events which initiate the buildup of cholesterol in arterial walls
(Grundy, 1990). One theory is an injury to the arterial wall is caused by high blood
pressure, viruses, chemicals or some other factor (Brown & Goldstein, 1984). Another
theory suggests that the presence of high levels o f blood cholesterol causes injury to the
arterial wall (Brown & Goldstein, 1984). Inside the artery wall, as the injury occurs,
oxidized LDL cholesterol binds to scavenger receptors located on the surface o f the white
blood cells. The white blood cells fill up with the oxidized LDL cholesterol and burst
depositing cholesterol to form a fatty streak inside the artery wall. This process leads to
an excessive amount o f cholesterol, smooth muscle cells and fibrous tissue called plaque.
The plaque will collect calcium causing it to became hard. Blood clots wUl form around
the plaque causing the artery to narrow and lose it’s elasticity. The artery becomes
blocked and will no longer allow blood flow to supply oxygen and nutrients to the ceU,
leading to the death o f cells (Smolin & Grosvenor, 1997).
Atherosclerotic lesions in the coronary arteries lead to CHD, which is the most
common and most serious o f cardiovascular diseases in middle-aged adults (National
Research Coimcil, 1989). If atherosclerosis causes interference with blood flow to the
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myocardium a Myocardial Infarction results. One third o f aU myocardial infarction
cases, coronary artery occlusion is the cause o f death in myocardial cells (National
Research Council, 1989). Patients may also suffer from failure o f the heart to pump
sufficient blood, known as congestive heart failure, or irregular heart beats, known as
arrhythmias. The presence o f severe lesions in the coronary arteries will often cause
angina pectoris, especially on exertion (National Research Council, 1989).
Cholesterol has received much attention, especially in view o f the well known
clinical fact that certain diseases and syndromes often associated with
hypercholesteremia, including diabetes mellitus, the nephrotic syndrome, myxedema, and
familial hypercholesteremia, predispose to premature atherosclerosis. In spite o f the fact
that cholesterol levels are often above 260 mg in persons with atherosclerosis, there is
evidence that a high proportion o f people develop atherosclerosis with blood levels in the
normal range o f 125 to 260 mg (Barry, 1997).
Incidence o f CHD varies widely from one country to another, which sparked the
interest o f researchers to answer the question o f why cholesterol in blood and coronary
heart disease is so different between countries (Frayn, 1996). Researchers started by
looking at international coronary artery disease mortality data and autopsy records from
cross-population studies which provided evidence supporting a significant association
between CAD and dietary fat intake (Caggiula & Mustad, 1997). The Seven-Country
study and the Japan-Honolulu-San Francisco study established the importance o f the fatty
acid composition o f dietary fats with the link o f increased rates o f CHD.
In the “Seven Country Study” dietary intake o f the participants was done by a 7day food record and then a sample o f each food consumed was chemically analyzed. The
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results showed in Finland and the United States total fat intake was 40% o f energy and in
Japan it was 20% o f energy. Saturated Fatty Acid (SFA) intake ranged from 20% in the
United States to less than 10% o f energy in Japan. This study was the first to show a
strong correlation between SFA, coronary artery disease and death. This study showed
that coronary artery disease rates were low despite moderately high total fat intakes,
especially when SFA intakes were high (Keys, 1970).
Three middle-aged men o f Japanese ancestry living in either Japan, Honolulu or
San Francisco participated in a study observing the relation between SFA, cholesterol and
heart disease. The intake o f total fat differed significantly among the three different
cultures. In Japan the percent o f energy from fat was 15%, in Honolulu it was 33% and
San Francisco participants SFA intake ranged from 7%, 13% and 38% (Kato, Tilloston,
Nichaman, Rhodes & Hamilton, 1973). Coronary artery disease mortality was 1.7 times
higher in Hawaii and 2.8 times higher in San Francisco than in Japan. Although no single
dietary factor existed that is associated with coronary artery disease between and within
aU different countries the mortality in these populations SFA and cholesterol are
generally positively correlated with coronary artery disease (Kato et. al., 1973).
There are specific differences in death rates from coronary artery disease among
most industrialized countries (Shils & Young, 1988). The highest rate o f CAD in males
between 35 and 74 years is seen in Finland and the United States. Eastern Europe and
Japan are about one fifth o f that in the United States. These differences in CAD maybe
due to genetic factors, but as seen with Japanese migrants to the United States they have
rapidly accumulated the risk o f artherosclerosis through western diet and lack o f exercise
(Shils & Young, 1988). Evidence suggests that cultural and environmental factors
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including diet may have an important part in CAD, but genetics probably explains the
difference in CAD among individuals from the same ethnic and cultural background
(Shils & Young, 1988).
There are a number o f conditions and habits that are correlated with the incidence
o f CAD and these have been termed “coronary risk factors” (Dawber, 1975). Nonreversible risk factors or otherwise known as primary risk factors are aging, male sex and
genetic traits: i.e. positive family history o f premature atherosclerosis (Dawber, 1975).
Potentially reversible risk factors or Secondary risk factors are: cigarette smoking,
hypertension, obesity, hyperlipidemia, hypercholesterolemia, hyperglycemia, diabetes
mellitus, low levels o f HD L’s and sedentary lifestyle (JAMA, 1993). Other possible risk
factors are body build, emotional stress and personality type (JAMA, 1993).
Hyperlipidemia consists o f increased plasma levels o f cholesterol and/or
triglycerides (Dawber, 1975). The elevated plasma hpid levels result from one or more
abnormalities o f lipid metabolism or transport (Dawber, 1975). Hypercholesterolemia
and hypertriglyceridemia seem to play an important role in the development o f
atherosclerosis.
Hypercholesterolemia is associated with increased incidence o f premature CAD,
but it’s importance varies in relation to age. The incidence o f myocardial infarction in
individuals between the ages o f 30 and 49 with cholesterol levels greater than 260 mg/dl
was three to five times higher than in individuals with cholesterol levels less than 2 0 0
mg/dl (Bierman & Ross, 1977).
Hypertriglyceridemia has a significant relationship to CAD due to increased
triglycerides and very low density lipoproteins (VLDL) (Assmann & Schulte, 1992).
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Individuals with elevated VLDL levels may have an increased risk for premature
atherosclerosis due to the fact that high levels o f VLDL will be transformed into LDL
and an even higher risk if the individual has other risk fectors such as diabetes, smoking
and hypotensive (Assmann & Schulte, 1992).
Goldstein (1973) studied the role o f genetics o f hyperlipidemia in atherosclerosis
in 500 survivors o f myocardial infarctions. The study showed that approximately one
half o f the males and two thirds o f females below the age o f 50 had either
hypertriglycerdemia, hypercholesterolemia or both. In the individuals over 70 the
presence o f atherosclerotic coronary disease was high, but no males and one fourth o f the
females had hypertriglycerdemia or hypercholesterolemia. It appears that hyperlipidemia
is more o f a risk factor in individuals below the age o f 50, and for men and women over
the age of 65, however, there is no evidence to support a correlation between
hyperlipidemia and atherosclerosis (Goldstein, Hazzard, Schrott, Bierman & Motulsky,
1973).
Cholesterol and Fiber
Treatment o f high total blood cholesterol begins with dietary therapy. The goal o f
dietary therapy is to lower LDL-cholesterol to levels under 130 mg/dl if definite CHD or
two other CHD risk factors are present (Expert Panel, 1993). The general purpose o f
dietary therapy is to reduce elevated cholesterol levels while maintaining a healthy
adequate diet. Modification o f the patient’s diet is an essential element of therapy
(Expert Panel, 1993). One o f the important modifications to help reduce high levels o f
cholesterol through diet is to increase the intake o f dietary fiber (Anderson et al., 1991).
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The effect o f fiber in various disease conditions has been studied for several
years. British scientists in the 1960’s concluded that many diseases and disorders o f the
Western society were related to a low intake o f dietary fiber (Council on Scientific
Affairs, 1989). They compared Western cultures to rural Afirican blacks and found that
cancer o f the colon and gastrointestinal disorders were rare in this society due to highfiber diets and production o f soft stools in large volume (Council Scientific Affairs,
1989). In Western cultures where life-styles and diet contain high amounts o f saturated
fat and low amounts o f fiber the incidence o f heart disease is much higher (Council
Scientific Affairs, 1989).
Dietary fiber has been shown to have an important lipid lowering effects and may
reduce risk for coronary artery disease (Anderson & Tietyen-Clark, 1986). Dietary
fibers, are the endogenous components o f plant material in the diet that are resistant to
digestion by enzymes produced by man (Pilch, 1987). Dietary fibers can be classified
according to their water solubility. Most water insoluble fibers such as cellulose,
cellulose-rich products and lignin (i.e. wheat bran) do not lower serum cholesterol
concentrations o f humans or animals (Anderson, 1987). Water-soluble fibers (pectins,
gums, and mucilages) and diets high in water-soluble fiber fi'om oats and bran decrease
the glycémie response to foods and lower serum cholesterol concentrations (Anderson,
1987).
The theories o f how fiber lowers cholesterol levels include the following: (1)
Soluble fibers bind bile acids and other lipids and may interfere with micelle fijnnation in
the small intestine resulting in alterations in the quantity o f cholesterol or fetty acids
absorbed or altering the size o f lipoprotein particles formed by intestinal mucosa (Council
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on Scientific AflFairs, 1989). (2) Soluble fibers increase the fecal excretion o f bile acids
and may interfere with cholesterol and bile acid homeostasis sufiiciently to affect hepatic
secretion o f lipoproteins. (3) Soluble fibers fermented by colonic bacteria form gases and
short chain fatty acids (Council on Scientific Affairs, 1989). Short Chain fatty acids are
almost completely absorbed into the portal vein and could effect hepatic cholesterol
synthesis (Council on Scientific Affairs, 1989). However various types o f dietary fiber
have different effects on serum cholesterol (Anderson & Chen, 1979). Soluble fiber
(Pectin, guar gum, barley and oat bran) have been shown to reduce blood cholesterol
levels, when given in large amounts (Life Sciences Research OfiBce, 1987). The fibers
fi-om fi-esh fimits, vegetables, legumes, oat bran and barley appears to have the most
potential for reducing cholesterol levels (Life Sciences Research Office, 1987). Insoluble
fibers such as wheat bran have a very small o r no effect on serum cholesterol levels
(Nutrition Committee, American Heart Association, 1988).
Anderson and associates (1991) studied 20 hypercholesterolemic men admitted to
a hospital metabolic ward. They were randomly divided into either an oat bran or wheat
bran group for 21 days after a 7-day control-diet period. Both the control and treatment
diets were designed to have the same energy content and nutrients, the only difference is
in the amounts o f soluble fiber. After the 21 day o f treatment oat bran significantly
decreased total cholesterol by 12.8% and lov/ density-lipoprotein cholesterol by 12.1%.
Wheat bran had no significantly change. In both groups high density lipoprotein did not
change significantly. They concluded that oat bran could have been effective in
reducing the risk for CHD, since they found a significant reduction in total cholesterol
and low density lipoproteins (Anderson et al., 1991).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

19
Kestin, Moss, Clifton and Nestel (1990) had similar findings on 24 mildly
hypercholesterolemic men on the effects o f adding 11.8g dietary fiber per day from each
o f three cereal brans (wheat, rice and oat) to a low-fiber diet for 4 weeks each. The
subjects were placed on a low-fiber diet for 3 weeks and randomly allocated to consume
the wheat, rice, or oat-bran supplement for 4 weeks in a double-blind crossover design.
Altogether there were six orders o f treatment and the study lasted 90 days. At the end o f
each period a fasted blood draw was done. Plasma total and low-density lipoprotein
cholesterol concentrations were significantly lowered by oat bran. Oat bran significantly
lowered the plasma total cholesterol concentration by 5.6%. This decrease was seen
mainly in the LDL-cholesterol Auction. In both the rice and oat bran a slight increase
was seen in the HDL cholesterol concentration o f 2.9% in rice bran and 4.0% in the oat
bran when compared with the wheat bran. They concluded that an increase intake of
fiber-rich foods from several sources might help prevent coronary heart disease and
cancer. However, the consumption o f a single food source o f fiber such as oat bran or rice
bran is unlikely to help lower plasma lipoprotein concentrations (Kestin, Moss, Clifton &
Nestel, 1990).
Oat-bran is a palatable cereal which is rich in water-soluble fiber (Kestin, Moss,
Clifton & Nestel, 1990). Oat products, have important hypocholesterolemic properties as
demonstrated in both humans and animals (Judd & Truswell, 1988). A 6 week study
looking at oat-bran supplementation o f 50g per day in the diets o f 12 healthy young
people showed a decrease o f serum cholesterol by 12% (Storch, Anderson & Young,
1984). In studies using larger intakes o f oat bran serum total cholesterol lowered by 13-
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19% and LDL cholesterol lowered by 14-23% with no change seen in HDL cholesterol
(Anderson, Story, Sieling, Chen, Petro & Story, 1984).
Anderson et al. (1990) studied 12 men with high serum total cholesterol
concentrations to determine the effects o f a ready-to-eat oat bran cereal on lipid
concentrations. Subjects were randomly assigned to either 56g o f oat bran cereal or com
flakes. Both diets were 43% o f energy from carbohydrate, 41% fat, 16% protein. After
completing the first diet, subjects completed 2 weeks on the alternate diet. The oat bran
cereal diet compared with the com flakes diet lowered semm total cholesterol by 5.4%.
LDL cholesterol decreased by 8.5% and HDL cholesterol decreased by 3.3% on the oat
bran diet (Anderson, Spencer, Hamilton, Smith, Tietyen, Bryant & Oeltgen, 1990).
Kirby, Anderson, Sieling, Rees, Chen, Miller and Kay (1981) had similar findings
on eight men who were fed control and oat bran diets with previously documented
hypercholesterolemia. The men were fed two identical solid diets that only differed in
the inclusion o f 1OOg o f oat bran per day provided in muffins and hot cereals. Each 1OOg
o f the oat-bran preparation contained 26.4g o f plant fiber including 14.8g o f watersoluble fiber. The diets were randomized alternating each group to the other diet after 10
days. Serum concentrations o f total cholesterol, triglycerides and glucose were measured
daily after a 10 hour fast. They measured plasma HDL cholesterol concentrations on 2 or
3 days at the end o f each dietary period and calculated values for LDL cholesterol.
Patients tolerated both diets well and ate 94% o f the oat bran served. The non-bran
control diets had a 5% increase on serum total cholesterol concentrations and in the oat
bran group an 18% decrease in serum cholesterol concentrations. The decrease in total
semm cholesterol was from a 14% reduction in LDL cholesterol whereas the cholesterol
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concentrations did not change. Concluding that palatable and inexpensive high fiber
foods such as oat bran may have an important role in treating hypercholesterolemia.
Anderson et al. (1984) examined 20 hypercholesterolemic men who were
randomly allocated to oat-bran o r bean supplemented diets for 21 days in a hospital
metabolic ward. They developed control and experimental diets that were virtually
identical in nutrient content and differed only in the amount o f plant fiber. The oat-bran
diet provided lOOg o f oat bran per day served as hot cereal and five oat-bran muffins a
day. Oat-bran diet supplied approximately 47g total plant fiber and 17g soluble fiber per
day. The bean diet contained 115g o f dried bean per day, which provided approximately
the same amount o f total plant fiber and soluble fiber as did the oat-bran diet. After the
21 days a 10 hour fasting blood draw was taken to measure serum cholesterol,
triglyceride and HDL cholesterol. The subjects ate 98% of the oat bran provided and an
average o f 88% o f the beans served. Subjects consumed the oat-bran without difficulty.
The subjects who consumed the beans complained o f mild abdominal distension and gas
production. Oat-bran diets decreased serum cholesterol concentrations by 19% and lowdensity hpoprotein cholesterol by 23%. Bean diets decreased serum cholesterol
concentrations by 19% and low-density lipoprotein cholesterol by 24%. Oat-bran
supplements and bean supplements had almost identical effects on serum total cholesterol
by reductions o f approximately 19% and LDL cholesterol concentrations by about 24%.
Neither diet was accompanied by substantial reductions in HDL cholesterol
concentrations. They concluded that oat-bran or bean supplement might have substantial
therapeutic benefits in the long-term management o f selected patients with
hypercholesterolemia.
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These studies document the hypocholesterolemic effect o f soluble-fiber rich foods
(Anderson & Chen, 1979). The lipid lowering effects o f soluble-ffbers such as guar gum,
locust bean gum, pectin, oat bran, legumes and psyllium have all shown significant
cholesterol lowering effects (Anderson et al., 1992). Considering the side effects o f
many cholesterol lowering drugs adding soluble fiber to the diet has been suggested as a
safe, practical and cost effective alternative to help reduce serum cholesterol
concentrations and may have a substantial impact in lowering the risk for CHD (Kinosian
& Eisenberg, 1988; Witztum 1989, Anderson, Deakins, Floore, Smith & Whitis, 1990).
Cholesterol and Exercise
Individuals who engage regularly in cardio-respiratory activities are leaner and
more physically fh in general than sedentary individuals. They also are reported to have
higher plasma concentrations o f high-density lipoprotein cholesterol (HDL-C) and lower
concentrations o f total cholesterol, low-density lipoprotein cholesterol (LDL-C), verylow-density lipoprotein cholesterol (VLDL-C), and triglycerides than sedentary control
subjects (Williams, Wood, Haskell & Vranizan, 1982). It is still uncertain whether
physical activity can favorably influence the process o f coronary artery disease and
coronary heart disease in human beings (Kramsch, Aspen, Abramowitz, Kreimendahl &
Hood, 1981). Recent studies appear to support the belief that regular aerobic exercise
may protect against premature cardiovascular disease (Kramsch et al., 1981).
Observations firom early investigations indicated lower triglyceride concentration in
endurance-trained subjects while total cholesterol was either not changed or only slightly
different. However, it became evident that physical activity had an impact on the
lipoprotein lipid distribution, and later investigations have focused on the measurement o f
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both the cholesterol and protein content associated with these various lipoproteins
(Kendler, 1997). In most cases, regular participation in physical activity is associated
with lower plasma triglyceride concentrations. Generally, when a person’s base line
plasma triglyceride concentration is elevated endurance exercise training usually can
reduce the high concentration (Thompson, CuUianane, Sady, Glynn, Chenevert &
Herbert, 1991). The amount o f the concentration that is reduced is related to the pre
training concentration and the volume o f exercise completed during the training program
(Guntelberg, Brennan, Holloszy, Schonfeld, Rennie & Weidman, 1977). Researchers
believe that reduction in triglyceride concentrations result from both regular exercise and
diet. Even though changing ones dietary intake can help with lowering triglyceride
concentrations alone. It does not seem to be the absolute reason seen in people who are
physically active (Kiens, Gad, Lithell & Vessby, 1981). This is portrayed especially in
endurance athletes, extreme leanness is related to lower triglyceride concentrations
(Hagan & Gettman, 1983).
Holloszy, Skinner, Toro and Cureton, (1964) studied the effects o f a six month
program o f endurance exercise on serum lipids o f middle-aged men. Two groups o f
subjects were involved in this study. In group A. 15 men who all led sedentary lives for
three or more years before the study participated in an organized exercise program
consisting of pushups, sit-ups and distance running (2 to 4 miles) on an average o f 3.35
times per week for six months. In group B. 12 subjects did not exercise together with an
instructor, but participated in a program o f distance running geared to their individual
capacities and increasing progressively in intensity. Three festing blood sangles were
taken on each subject over a seven day period to establish base line values. Total serum
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cholesterol levels were determined once a month, and phospholipids along with
triglycerides measured every other month. AU three samples were taken over a seven day
period after the study. The results o f the serum triglycerides fell from a mean pre
training o f 208 ± 127 to 125 ± 78 mg. in both groups. The mean serum cholesterol and
phospholipid levels did not change significantly with training. This reduction in serum
triglycerides appears to occur within two to three hours after exercise and lasts for
approximately two days. From their results they concluded that it would appear that
serum triglyceride levels can be kept significantly lower by means o f regularly performed
endurance exercise. This finding may represent one mechanism by which exercise
possibly could protect against coronary heart disease. (HoUoszy, Skinner, Gelson &
Cureton, 1964).
Cholesterol is an important part o f ceU membrane and synthesis o f steroid
hormones however; excess (high levels oQ cholesterol is also associated with
development o f coronary artery disease. Studies have concluded differently on whether or
not plasma cholesterol concentrations are lower in endurance-trained male and female
athletes when compared to inactive control groups (Williams, Krauss, Wood, Lindgren,
Giotas & Vraganizan, 1986).
Factors such as body weight, percentage o f body fat and differences in fe»od intake
are important considerations when evaluating the effects o f physical activity on plasma
cholesterol concentration. Factors such as age and gender can play an important role in
the difference o f plasma concentrations, which can effect whether or not physicaUy active
individuals have lower plasma concentrations than do inactive individuals (Seals,
Hagberg, Hurley, Ehsani & Holloszy, 1984).
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Studies comparing LDL-C concentrations in men and women athletes from
various sports with those o f inactive subjects have produced mixed results (Thompson,
Callinane, Sady, Flynn & Bernier, 1988). Tsopanakis, Kotsarellis and Tsopanakis (1986)
found that athletes participating in power or speed-related events have LDL-C either
similar or lower than those o f inactive controls. Stein, Michielli, Glantz, Sardy, Cohen,
Goldberg and Brown (1989) found similar findings as Tsopanakis when studying the
effects o f different exercise training intensities on lipoprotein cholesterol fractions in
healthy middled-aged men. They reported that LDL-C concentrations are lower for men
and women following endurance training. However, in one study conducted by Marti,
Suter, Riesen, Tschopp, Wanner and Gutzwiller (1990) that looked at only men and
another study conducted by Nikkila, Kuusi and Myllyen (1980) looked at both men and
women long distance runners reported lower LDL-triglyceride concentrations in men but
not in women when compared with inactive controls. However, a study conducted by
Kuusela, Vautilainen, Kukkonen and Raurammaa (1980) compared Scandinavian
lumberjacks with sedentary workers and concluded that lumberjacks have higher LDLtriglyceride concentration.
Endurance-exercise training has been associated with increased HDL-C
concentration, associating it with reduced CAD risk. There is a consensus, among crosssectional studies that HDL-C concentrations are elevated typically 20-30% in endurance
trained athletes when compared to inactive groups (Thompson, Lazarus, CuUianane,
Henderson & Musliner, 1983). Some researchers have suggested a dose-response
relationship between the amount o f exercise performed and how much HLD-C will
increase (Rotkis, Cote, Coyle & Wilmore, 1982). Some researchers do not believe that
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one bout o f exercise can have an effect on HDL-C increasing. Reasons for the
discrepancy may be related to several factors: the length o f the training period, the
volume o f training period, the volume o f training completed, changes in body
composition, dietary intake, weight loss, and the pre-training HDL-C concentrations
(Weltman, Matter & Stanford, 1980).
Brownell, Bachorik and Ayerle (1982) studied the effect o f a 10 week exercise
program on changes in plasma lipid and lipoprotein levels in 37 women and 24 men.
Thirty-minute sessions were held three times weekly for 3 different groups o f 15-25
subjects. The class was conducted by certified fitness instructors and focused on
cardiopulmonary conditioning, flexibility, muscular strength and endurance. By the
fourth week, the subjects were exercising at approximately 70% o f maximal heart rate for
15-20 minutes. The remaining time was used for warm-up, cool-down and stretching.
Blood samples were obtained before and after the 10-week program. Results fi'om this
study demonstrate that men and women differ in their lipid and lipoprotein responses to
an exercise program Men showed significant reductions o f 4.4% in cholesterol 6% in
LDL cholesterol and 9.5% in triglycerides and a 5.1% increase in HDL cholesterol.
Women showed a 4.1% decrease in cholesterol with no significant changes in HDL
cholesterol or LDL cholesterol and a 14.5% decrease in triglycerides. The results fi'om
the study concluded that moderate exercise might have different effects on men and
women (Thompson, Lararus, Cyllianane, Henderson & Musliner, 1983).
Studies on exercise and lipid changes have proposed conflicting results between
men and women. Studies o f men have shown consistent increases in HDL cholesterol
during programs o f moderate or intensive exercise and have shown either a decrease or
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no significant change in triglyceride. The HDL/LDL ratio, an important predictor o f
coronary heart disease, increased significantly in men, but did not change significantly in
women when participating in an exercise program. Conclusions o f this matter suggests
that a short-term exercise program in a work setting can improve plasma lipid and
lipoprotein patterns more in men than in women (Brownell et al., 1982).
In women, some studies showed no change in HDL cholesterol and a decrease in
LDL cholesterol after moderate exercise (Lee, Nieman, Raval, Blankenship & Lee,
1991). In addition, it is becoming increasingly apparent fi'om studies that the quantity
and intensity o f physical activity required to have a positive change in lipoprotein levels
may be varied (Leon, Connet, Jacobs & Rauramaa, 1987). For instance, it has been
shown recently that more moderate levels o f activity can improve the lipoprotein profile
by increasing HDL cholesterol levels and lowering LDL cholesterol levels (Duncan,
Gordon & Scott, 1991). Researchers thought one would need to endurance train to show
significant changes in cholesterol levels.
King, Haskell, Young, Oka and Stefanick (1995) studied 149 men and 120
postmenopausal women to determine the two-year effects o f differing intensities and
formats o f endurance exercise on exercise participation rates, fitness, and plasma HDL
cholesterol levels among healthy older adults. The subjects were randomly assigned to
one o f four groups. (1) higher-intensity group-based exercise training (2) higherintensity, home-based exercise training (3) lower-intensity home-based exercise training
(4) a 1-year delayed treatment control condition that received an exercise training
program during the second year. The primary purpose o f the second study year was to
evaluate the maintenance o f changes that had occurred during the first year in the three
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experimental conditions. It also allowed the researchers to look at long-term effects of
the three different exercise-training conditions on variables such as lipoprotein levels that
had not changed significantly during the first year. For the higher-intensity exercise
training, three 40-minute endurance training sessions per week were prescribed at 73% to
88% o f peak treadmill max heart rate. For lower-intensity exercise, five 30-minute
endurance training sessions per week were prescribed at 60% to 73%. Subjects assigned
to the year delayed treatment control condition were requested not to change their activity
habits during the initial 12-month study period. Changes in total cholesterol, HDL, LDL
cholesterol and plasma triglycerides did not differ significantly between the three
exercise training conditions versus the one-year wait-listed control group at the end o f 1
year. By the end o f the second year subjects in the two home-based training conditions
showed small but significant HDL cholesterol increase fi'om baseline. The increases
were the greatest for subjects in the lower-intensity condition, whose exercise
prescription required more frequent exercise sessions per week. In all exercise
conditions, increases in HDL cholesterol were associated w ith decreases in waist-to-hip
ratio in both men and women. Concluding that frequency and length o f time needed to
achieve HDL cholesterol change may be longer for older populations (King, Haskell,
Young, Oka & Stefanick, 1995).
Stein et al. (1989) studied the effects o f different exercise intensities on
lipoprotein cholesterol fiuctions in healthy middle-aged men. Forty-nine healthy men
were randomly divided into four different groups o f exercise training. The subjects
trained at either 65%, 75% or 85% o f their measured maximal heart rate. The fourth
group was a 12 week non exercise control group. Fasting morning blood samples were
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obtained from all subjects before and immediately after the exercise training or control
period. Results o f the lipid profiles showed that total cholesterol did not change
significantly in any o f the groups HDL cholesterol increased significantly in the 75% and
85% maximal heart rate training groups, but not in the other two groups. LDL
cholesterol decreased significantly only in the 75% group. No significant differences
were seen with in any o f the groups for VLDL cholesterol or triglyceride levels.
Concluding that an aerobic exercise at 75% maximal heart rate, 30 minutes per session, 3
days a week for 12 weeks results in a 19% increase in HDL cholesterol and an 22%
decrease in LDL cholesterol (Stein et al., 1989).
Elevated levels o f plasma high-density-lipoprotein (HDL) may be associated with
a lowered risk o f coronary heart disease (Gordon, Castelli, Hjortland, Kannel & Dawber,
1977). Several studies have indicated that vigorous exercise training may result in
elevated HDL cholesterol levels in young and middle aged men (Lopez, Vial, Balart &
Arroyave, 1974). The concept o f elevated HDL levels resulting from exercise has been
combined with the idea o f the effect which dietary modification may have on HDL levels
(Sacks, Castelli, Donner & Kass, 1975). Some researchers have suggested that moderate
alcohol intake and a reduction caloric intake will increase HDL levels. Hartung, Foreyt,
Mithcell, Vlasek and Gotto (1980) studied 59 healthy middle aged marathon runners, 85
joggers and 74 inactive men and observed the relation between diet and plasma lipids and
lipoprotein levels in all o f these men. The inactive subjects were men selected randomly
from the general population who indicated that they did not exercise regularly. They
participated in a diet-education study and were randomized into a control group. The
marathon runners had aU completed a 26.2 mile marathon during the 12 months before
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the study and continued to train heavily. They reported an average o f 40 miles per week.
The joggers ran at least 2 miles three times per week. Blood was drawn in the morning
after a 12 to 16 hour fast. Height, weight, tricep skinfold and blood pressure were also
measured and a comprehensive questionnaire was completed during the visit on the fi>odintake-record section the subject was asked how many servings o f each food he ate daily
weekly, monthly or yearly. The marathon runners and joggers did not differ substantially
fi’om the inactive subjects in their reported dietary habits, although they had significantly
higher HDL-cholesterol levels. The positive relation between distance running and HDL
cholesterol was significant. The distance ran was the best predictor o f both HDL
cholesterol and the ratio o f HDL to total cholesterol Concluding that it is primarily the
jogging and running, rather than diet that elevated HDL to a level associated with
significant reduction o f coronary risk (Hartung, Foreyt, Mitchell Vlasek & Gotto, 1980).
Hartung, Squires and Gotto (1981) found similar results in studying the effects o f
chronic exercise training on plasma HDL cholesterol on 18 male coronary patients.
Exercise training was conducted three times weekly for 20 minutes, increasing to 40
minutes per session at an intensity utilizing 70% to 85% o f the maximal heart rate for a
period o f 3 months. None o f the patients were placed on a specific diet. Blood was
drawn at the start o f the study ft) Howing a 12 to 14 hour fast and then again at the end o f
the 3 months. Hartung found similar results fi’om the previous study he conducted a year
earlier. Moderate physical activity ft)r 3 months can contribute to increases in HDL-C in
patients with coronary artery disease without dietary intervention or significant change in
total cholesterol triglycerides and body weight (Hartung, Squires & Gotto, 1981).
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Regular participation in physical activity as well as single exercise session can
alter lipoprotein metabolism, plasma lipid and lipoprotein concentrations and lipid
transport (Durstine & Haskell, 1994). The understanding of the precise mechanisms
responsible for these changes is not totally clear. There is evidence indicating that other
factors including diet composition adiposity, weight loss, plasma volume change, and
hormone and enzyme activity interact with exercise to alter the rates o f synthesis,
transport and clearance o f lipid and lipoproteins from the blood (Durstine & Haskell,
1994).
Lipoprotein Lipase (LPL) is responsible for delipidation o f chylomicron and
VLDL molecules and promotes the clearance o f fatty acids and glycerol from the
vascular compartment for either storage or use as substrate in energy metabolism
(Durstine & Haskell, 1994). Cross-sectional studies indicate that endurance-trained
runners at rest have higher plasma concentrations o f LPL activity than less active controls
(Thompson et al., 1991). Inactive men, after undergoing endurance-exercise training,
usually have significantly lower adipose tissue and LPL activity than compared to their
adipose tissue when they were inactive. (Peltonen, Mamiemi, Hietanen, Vuori &
Ehnholm, 1981).
Studies evaluating a single exercise session indicates that it increases LPL
activity. Depletion o f intramuscular triglyceride stores by endurance exercise may
promote secretion and/or synthesis o f LPL by muscle cells (Oscari, Essig & Palmer,
1990). Kanter, Cullinane, Sady, Herbert and Thompson (1987) studied 21 trained and
untrained men on the effect o f a single exercise session on lipid and lipoprotein
concentrations and on plasma lipoprotein lipase. After the trained and untrained subjects
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performed a single prolonged session o f endurance cycling exercise both groups had
higher LPL activity.
Studies show that increased LPL activity results in increased HDL synthesis and
also indicates that exercise training also prolongs the survival o f HDL (Durstine &
Haskell 1994). The survival time o f HDL protein was 27% longer in the circulation o f
physically active men, compared with inactive men (Herbert, Bemier, Cullinane,
Edelstein, Kantor & Thompson, 1984). Endurance training increases the half-life o f
apoliproteins A-I and A-H in active men (Thompson et al., 1988). Researchers have
concluded the increase o f HDL associated with endurance training is a result o f both
increased synthesis and survival.
Other factors should be considered when evaluating the impact o f a single session
o f exercise or exercise training on lipoprotein metabolism. Controversy exists about the
effect o f dietary modification on lipoproteins (Sacks et al., 1975). Some researchers have
suggested that moderate alcohol intake or caloric restriction resulting in weight loss may
elevate HDL (HuUey, Cohen & Widdowson, 1977). Reduced body fat and increased
leanness are important outcomes o f exercise training. Leanness has been associated with
lower hepatic lipase activity in physically active people (Wood & Stefenick, 1990).
Increasing one’s exercise and changing one’s diet will help reduce body fat and prevent
the incidence o f high cholesterol and occurrence o f heart disease.
The adipose distribution shown by waist-to-hip girth ratio (WHR) is associated
with altered lipoproteins (Durstine & H askell 1994). Abdominal adiposity with a WHR
greater than 1.0 in nonobese males is associated with lower HDL-C concentration
(Barakat, Burton, Carpenter, Holbert & Israel 1980). Studies have shown subjects with
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abdominal adiposity to have plasma LDL characteristics that look almost identical to the
LDL plasma o f subjects with CAD (Peeples, Carpenter, Israel & Barakat, 1989). This
may suggest, as a result o f endurance training, a selective loss o f abdominal fat versus
other areas (gluteal), a reduction in the WHR could perhaps reduce CAD risk (Peeples et.
a l 1989).
Physical activity has a positive effect on the lipid and lip>oprotein concentrations.
In normal men and women increased physical activity is associated with lower plasma
triglyceride concentrations (Durstine & Haskell, 1994). The dominant changes in
lipoproteins associated with endurance training are increased HDL-C, HDL2-C and
apoliprotein A-I concentration (Durstine & Haskell, 1994). Exercise-induced reductions
in LDL-C are only minor without change in adiposity or dietary fat cholesterol intake
(Durstine & H askell 1994).
Cholesterol Lowering Drugs
Patients whose LDL cholesterol levels remain high even with extensive dietary
therapy and exercise should be considered for drug treatment. Dietary therapy should be
at least six months long before drug treatment is started (The Expert Panel 1988).
Individual with elevated LDL cholesterol levels above 220 mg/dl and/or with confirmed
coronary heart disease, diet and exercise should not be the only therapy considered (The
Expert Panel 1988). After the required six months o f dietary therapy, to establish
adequate baseline values, drug therapy should be initiated. (The Expert P anel 1988).
There are about fourteen types o f cholesterol lowering drugs, which are grouped
into categories based on their action. Bile acid sequestrates: cholestyramine and
colestipal action binds acids in the GI tract, forming an insoluble complex resulting in
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increased clearance o f cholesterol binded to bile acids eliminated in the feces. Some o f
the most common side effects are nausea, constipation, abdominal discomfort, rashes and
skin irritations (Hopfer, 1995).
Nicotininc acid generally known as Niacin helps lower cholesterol levels by
decreasing lipoprotein and triglyceride synthesis by inhibiting the release o f free fatty
acids from adipose tissue and decreasing hepatic lipoprotein synthesis. Generally it
decreases blood lipids. Some major side effects are nausea and flushing o f the face and
neck (Hopfer, 1995).
Fibric acids: clofibrate, fenofibrate, gemfibrozil and benzafibrate works by
decreasing triglyceride production by the liver and increases HDL lipoproteins. Major
side effects consist o f diarrhea and abdominal pain (Hopfer, 1995).
Probucol is one o f the most common cholesterol drugs prescribed to date. It may
decrease transport o f cholesterol from intestine or interfere with cholesterol synthesis.
Also it may increase fecal excretion o f cholesterol and bile acids. The most common side
effects are diarrhea, bloating, abdominal pain, nausea and vomiting (Hopfer, 1995).
There are four HMG-CoA reductase inhibitors available on prescription in the
United States. Pravastin (provachol), Fluvastatin (lescol), and two o f the newest and
most common prescribed Lovastatin (mevacor) and Simvastatin (zocor). Also known as
“statins” these agents slow the progression o f coronary artery disease and have actually
been shown to induce regression o f artherosclerotic lesions in CAD patients (Pedersen,
1995). These drugs act by inhibiting the hepatic enzyme HMG-CoA reductase, which
leads to an increase in the hepatic production o f cholesterol receptors. These receptors
pull cholesterol out o f the blood stream, thus reducing serum cholesterol levels
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(Thompson et al.,1995). Statins have been associated with some skeletal muscle
con^laints (myositis and rhabdomyolysis). The most common side effects include
headache, abdominal pain, constipation, and diarrhea (Kobashigawa et al., 1995).
Patients should incorporate diet, weight control, exercise and stop smoking to
lower cholesterol levels and the risk o f CHD before any drug therapy is considered
(Expert Panel, 1993). I f these methods fail and cholesterol levels are not lowered drug
therapy should then be considered.
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Summary
Cholesterol is probably the best known sterol, which is essential to the human
body. It is found associated with the fats, but chemically it is not related to them.
Cholesterol, a white waxy solid, is the principal sterol found in animal organisms. The
largest amount o f cholesterol is found in muscle, nervous and connective tissue. It is
needed to synthesis vitamin D, cholic acid which is part o f büe, some hormones, and
cortisol which promotes glucose synthesis in the liver. The daily production is
approximately 400 mg from intestinal absorption and 600mg synthesized in the cells and
the Uver. In the human body every cell, except a mature red blood ceU, produces
cholesterol
The synthetic process o f cholesterol takes place in the liver and may occur in
other organs. In all tissues expect in the brain, cholesterol is continually regenerated. If
any organ can be singled out as the single most important to metabolize cholesterol and
some amount o f plant sterols, it is the liver. It can both synthesize and destroy
cholesterol. The breakdown and lose o f cholesterol can occur in four ways:
1. By direct reduction to dihydrocholesterol or by passage through the
intermediate cholesterone to dihydrocholesterol or coprosterol
2. By loss o f cholesterol in the feces.
3. By conversion into steroid hormones.
4. By conversion to bile acids in the liver.
There are a number o f variables that are important in determining or changing the level o f
blood cholesterol in the body. Throughout the day the level o f serum cholesterol remains
for the most part constant, even through there is a large variation in the rate that
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cholesterol enters and leaves the body. Females at birth have slightly higher levels o f
plasma cholesterol than males. During childhood, adolescence and early adulthood there
is very little difference in blood cholesterol between m en and women. In later life males
tend to have higher serum cholesterol levels due to higher concentrations o f VLDL and
LDL. Serum cholesterol levels tend to be a lower in premenstrual women. After the age
o f 50 male cholesterol levels tend to lower whereas females tend to rise slightly.
Artherosclerosis is the major disease affecting the heart and blood vessels, and is
the leading cause o f death among middle-aged adults in the United States.
Artherosclerosis is the result o f fatty cholesterol deposits in blood vessels walls, reducing
elasticity and eventually blocking blood flow. It is a disorder o f the coronary arteries,
cerebral arteries, iliac and femoral arteries and aorta that is responsible for coronary heart
disease, stroke and peripheral arterial disease.
Treatment o f high cholesterol begins with dietary treatment. There is evidence
indicating that dietary fiber has important hpid lowering effects and may reduce risk o f
CHD. Increasing dietary fiber intake is an important therapeutic treatment for other
specific conditions besides CHD, such as diabetes, hyperlipidemia, hyperglyceridemia,
hypercholesterolemia and intestinal disorders. Soluble fiber has been shown to reduce
blood cholesterol levels. Soluble fiber increases the fecal excretion o f bile acids, which
may alter the quantity o f cholesterol absorbed by the intestine. The fibers fi’om firesh
fruits, vegetables, legumes, oat bran and barley appear to have the most significance for
reducing cholesterol levels.
Individuals who engaged regularly in cardio-respiratory activities are leaner and
more physically fit in general than sedentary individuals. They also cholesterol (HDL-C)
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and lower concentrations o f total cholesterol, low-density lipoprotein cholesterol (LDLC), very-low-density lipoprotein cholesterol (VLDL-C) and triglycerides than sedentary
control subjects- Regular participation in physical activity as well as a single exercise
session can alter lipoprotein metabolism, plasma lipid and lipoprotein concentrations and
lipid transport. The understanding o f the precise mechanisms responsible for these
changes is not totally clear. There is evidence indicating that other factors including diet
composition adiposity, weight loss, plasma volume change, and hormone and enzyme
activity interact with exercise to alter the rates o f synthesis, transport and clearance o f
lipid and lipoproteins from the blood.
Patients who cholesterol levels do not lower with dietary and exercise therapy
drug intervention should be considered as a method o f lowering these high levels. There
are fourteen types o f cholesterol lowering drugs which are grouped into categories based
on the action they perform in the body; bile acid séquestrants, nicotininc acids, Fibric
acids, probucol and HMG-CoA. The goals o f drug therapy are to lower total cholesterol,
raise HDL’s and lower LDL’s. However, there are several major side effects. They
range from itching o f the skin, gastrointestinal distress, liver toxic effects, muscular
damage due to interaction between drugs and blood clots.
In summary, coronary heart disease (CHD) is the leading cause o f death in the
United States (JAMA, 1995). While factors such as obesity, diabetes, smoking,
sedentary living and hypertension have been shown to influence CHD risk, serum
cholesterol seems to have the strongest correlation with CHD (Genest & Cohn, 1995).
The real aim o f any cholesterol management intervention is to lower circulating
cholesterol fractions. The National Cholesterol Education Program Guidelines state that
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exercise along with a high fiber diet, weight loss and medication should be included in
the management o f high cholesterol filetions. It is important to know not only the
interactive effect o f exercise and diet on lipoprotein metabolism but also the interactions
between exercise and various classes o f lipid medications now used in treatment.
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CHAPTERS

METHODS
Subjects
Fifty (50) male and female subjects volunteered to participate in this study.
Twenty-five were exercising regularly in a supervised exercise program and the other 25
were sedentary. The twenty-five exercising subjects belonged to two formal exercise
programs. Twenty were from the Adult fitness program at the University o f Nevada Las
Vegas (UNLV). This program starts at a low level o f intensity and progresses in intensity
each week. Subjects meet as a group five days a week Monday through Friday. The
supervised exercise program consists o f four components: 1) warm-up and stretching, 2)
strength and muscular endurance, 3) cardiovascular or aerobic, and 4) cool down. The
warm-up period includes 5 to 7 minutes o f flexibility exercises, consisting o f bending,
stretching and twisting. Exercises for muscular strength and endurance include push-ups,
sit-ups and chest raising. For the aerobic pwrtion o f the class the women do bench steps
and jogging, and the men do bench steps and swimming. The final part o f the program is
a cool down period; these exercises are similar to the warm up exercises. The other five
were participating in their own exercise program at least 3 times a week for duration o f
30 minutes and at an intensity o f 70 % or more o f their max heart rate. The twenty-five
sedentary subjects were recruited from the Las Vegas community and the UNLV faculty
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and staff. All subjects had an LDL-C o f 130 mg/dl or higher and were not on any
cholesterol lowering medications. This study was approved by the Institutional Review
Board (See Appendix B).
Research Design
The study was divided into a pre-experimental period, an experimental period and
a post experimental period.
1). The 7 day pre-experimental period was for collecting baseline data.
2). The experimental period was 90 days in duration during which time the subjects
ingested the experimental fiber.
3). The post-experimental period was when final testing was done.
There were three testing periods. Test 1 (T l) during the pre-experimental period. Test 2
(T2) 45 days after starting the experimental period and Test 3 (T3) test during the postexperimental period.
Statistical Design
This study was a 2 (Group) by 3 (Time) mixed model with repeated measures
design with exercise being between subjects and time being within subjects. The two
levels o f exercise were exercise and non-exercise. The three levels o f time were baseline,
45 days and 90 days. The dependent measures o f interest were Total Cholesterol, LowDensity lipoproteins (LDL’s) and High-Density lipoproteins (HDL’s).
Procedure
Pre-experimental Period
During this period o f approximately one week the testing (T l) included a 12-hour
fasting blood sample. A lipid profile determined Total Cholesterol, HDL-C, LDL-C,
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VLDL-C, Cholesterol/HDL Ratio and Triglycerides. This lipid profile served as their
baseline blood profile if it was greater than 130 mg/dl. Since an LDL-C greater than 130
mg/dl was required to be in the study. If the LDL-C was less than 130mg/dl they were
eliminated fi-om the study. During this pre-experimental period, subjects were briefed on
the study, questions were answered and they read and signed an informed consent form
(Appendix B). Written information about Bios Life 2 was distributed to subjects
(Appendix A). Height and weight was measured and Body Mass Index was calculated.
Waist girth and hip girth were measured firom which a waist to hip ratio was calculated.
Body fat was determined by bioimpedance analysis. A six-minute walk test was
administered. The six-minute walk test was used to determine “fimctional exercise
capacity”, which is defined as a patient’s ability to undertake physical demanding
activities encountered in everyday life that are not reflected by conventional exercise
testing.
Experimental Period
During this 90-day experimental period the subjects in the exercise group
exercised a minimum o f three times a week and took the prescribed dosage o f Bios Life
2. The non-exercise group took the prescribed amount o f Bios Life 2 and did not change
their regular routine or eating habits. After 45 days all tests (T2) were repeated exactly as
performed in T l . This was Test 2 (T2).
Post-experimental Period
During this period all tests were again administered: Test 3 (T3). Test T3 was
administered as soon after the experimental period as possible. However, the subjects
continued the experimental protocol until they were tested.
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BiosLife 2
BiosLife 2 is a dietary fiber in the form o f a powder and packaged in 4.5-gram
packets. It was mixed with eight-ounces o f water or finit juice and one packet was taken
twice per day. It was taken 15 minutes prior to breakfast and dinner. (See appendix A for
ingredients). A dietary survey was completed on all subjects to determine the amount o f
fiber in their normal diet. (Appendix C). I f the diet was low in fiber subjects were
introduced to the Bios Life supplement gradually by taking one-half the normal dose for
the first three to four days. Subjects reported to the laboratory every two weeks during
the experimental period. During this time weight was taken and questions were asked
about the subject’s adherence to the experiment protocol and reported any side effects o f
the Bios Life. Every two weeks the subjects brought back their used and (any unused
packages) fi-om the prior two weeks. This was used to determine compliance.
Six-minute Walk Test
To determine a level o f cardio-respiratory fitness a submaximal six-minute walk
test was given. The six-minute walk test was done on a measured course. The distance
covered in six minutes was recorded and conqiared to national norms. The number o f
stops (or rest periods) during the walk were also recorded. The outdoor course, where the
test was administered, was on a concrete walkway and consisted o f 283 feet and 8 inches
per lap. In the center o f the course was a courtyard, which was surrounded by concrete
benches. These benches not only served as course markers they also provided a place to
sit if a rest was needed. The subjects were encouraged to walk as far as they could in the
6-minute period but were allowed to stop and rest if necessary. The distance and the
number o f stops were recorded for each subject.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

44
Anthropometrical Measurements
Height was taken without shoes with an anthropometer to the nearest quarter o f an
inch. Subjects were instructed to stand as tall as possible, feet together and looking
straightforward. Weight was measured, without shoes and minimal clothes, on a
physicians balance scale to the nearest quarter o f a pound. Body Mass Index was
computed from formula o f body weight in kilograms divided by height in meters squared
(BW (kg)/HT (m)^). Men with a BMI greater than 27, and women with a BMI greater
than 26.9 were considered overweight. (Appendix E). Waist girth was measured in
centimeters at the narrowest circumference and hip girth was taken at the largest
circumference. A waist to hip ratio o f greater than .9 was considered obese (See
appendix E for risks).
BMI and waist to hip ratio are commonly used in epidemiology studies to
describe the degree o f fatness in a population. Although these measurements were taken
at T l, T2 and T3 they are measurements that do not usually reflect body composition
changes in an individual over time, but were used to describe the population.
Bioimpedance Analysis (BIA)
Bio impedance analysis was done using the Bio Analgesics system A low-grade
electric current is passed through the body, which is resisted, by body water. This
resistance is measured in Ohms. This resistance is used in an equation to determine total
body water. Total body water is then used to calculate per cent body fet.
Cholestech LDX
The cholestech LDX Analyzer is a small size (5”x 5” x 8”) lightweight (21b)
instrument designed for point o f service lipid analysis. The analyzer uses a disposable
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cassette that needs only 35 uL blood sangles, which can easily be obtained by a
fingerstick. The cassette contains a well into which the blood is pipetted, a glass fiber
screen, four optical windows, a reagent impregnated bar allowing four separate reactions
and a magnetic code bar to communicate with the analyzer. The blood is separated by
the glass fiber screen that allows only the plasma into a reservoir. The system than uses
reflectance photometry to obtain lipid results. The instrument has a display window that
guides the user and displays the results, which are available within four minutes
(Drimmer et al., 1995).
Optics Check Cassette Test Procedure
Before any procedure is performed the analyzer must be tested. The Cholestech
Optics Check Cassette should be ran once each day before patient samples are tested and
after the cholestech L.D.X System has been moved or serviced. One should never use the
Cholestech L.D.X Optics Check Cassette that has become damaged or altered in anyway.
The cassette is placed in the analyzer and the test is run. The analyzer will automatically
perform the optics check. Once the test is complete four numbers will appear on the
screen and if they are within the acceptable range (80-105) a blood sample can be ran.
Performing a Fingerstick
The patient was asked to sit quietly for five minutes before the blood sanple was
taken. Gloves were worn while working with the blood sample and the samples were
placed into the biohazard box when the test was completed. A capillary plunger was
placed into the end o f a cholestech capillary tube with the red mark and set aside. To
help increase blood flow, the fingers and hands were warm to the touch. I f not the
capillary puncture was done on center fingers that has been thoroughly cleaned with an
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alcohol swab. The area was thoroughly dried with a gauze pad before pricking the finger.
Then the center fingers were firmly pricked with the lancet. The finger was squeezed
gently to obtain a large drop of blood. The first drop o f blood was wiped away due to the
fact it may contain tissue fluid. The finger was gently squeezed again while holding it
downward until a second large drop o f blood forms. The puncture should provide a fireeflowing drop o f blood. The capillary tube was held horizontally by the end with the
plunger, then touched to the drop o f blood without touching the skin. The tube will fill
by capillary action up to the black mark. A very important step is not to collect air
bubbles. The excess blood was wiped off and then the patient applied pressure to the
puncture until the bleeding stopped.
Performing the Test
The fingerstick sample was analyzed within 5 minutes after the collection or the
blood wUl clot. The cassette was taken out o f the refiigerator and warmed up to room
temperature for 10 minutes before opening. The Analyzer is plugged in and warmed up.
The cassette was removed from its pouch and held by the short sides only. Do not touch
the black bar or the brown magnetic stripe. The cassette was placed on a flat surface.
Press run on the analyzer first so that a self-test can be ran. Once a Self-Test is ok the
cassette drawer will open and load cassette will appear on screen. Use the Cholestech
capillary tube to place sample into the test cassette sample well. Keep the cassette level
after the sample has been applied. Immediately place the cassette into the drawer o f the
analyzer. The black reaction bar must free toward the analyzer. The brown magnetic
strip must be on the right. By pressing run the drawer will close and the testing begins.
When the test is conqileted, the analyzer will beep and the screen will display the data.
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Everything that came into contact with blood including the cassette was placed into a
biohazardous container. The results were recorded on the appropriate form.
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CHAPTER 4

RESULTS & DISCUSSION
Mean total cholesterol and low-density lipoproteins were analyzed using a 2
(group) by 3 (time) analysis o f variance (ANOVA) procedure with repeated measures on
the second factor. All statistical analysis was done using the SAS system.
Total Cholesterol
The test for interaction was not significant F = 0.00, p = .9985. The ANOVA did
however yield a significant main effect for time, (F = 18.29, p = .0001), with means for
the exercise group being 242, 233,222 and the means for the non-exercise group being
246, 237, 226 for baseline, 45 days and 90 days, respectively (see figure 1). Tukey’s test
was used to determine the nature o f the difference. This indicated a significant decrease
in total cholesterol at each measure baseline, 45 and 90 days in both exercising and non
exercising groups.
The ANOVA did not yield a significant main effect for group, (F = 0.20, p =
.6540), with means being 232, 236 for exercise and non-exercise, respectively (see figure
2). Therefore, there was a significant decrease in total cholesterol for the exercise and
non-exercise groups, but there was no significant difference between exercise and non
exercise.
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Figure 1
Total Cholesterol over Time
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Total Cholesterol and Exercise Group
270
_

250

#230

a Baseline

■
S
5 210

■ 45 Days

U
5

O

□ 90 Days

190
170
150
E xercise

Non-Exercise

Low Density Lipoprotein Cholesterol
The test for interaction was not significant F = 0.72, p = .4896. The ANOVA did
however yield a significant main effect for time, (F = 21.60, p = .0001), with means for
the exercise group being 161, 154, 139 and the means for the non-exercise group being
151,144, 135 for baseline, 45 days and 90 days, respectively (see figure 3). Tukey’s test
was used to determine the nature o f the difference.
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Figure 3
LDL Cholesterol over Time
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This indicated a significant decrease in LDL cholesterol at each measure from
baseline to 90 days in both exercising and non-exercising groups. The ANOVA did not
yield a significant main effect for group, (F = 1.59, p = .2128), with means being 151,
158 for exercise and non-exercise respectively (see figure 4). Therefore, there was a
significant decrease in LDL cholesterol for the exercise and non-exercise groups, but
there was no significant difference between the exercise and non-exercise.

Figure 4
LDL Cholesterol and Exercise Group
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High Density Lipoprotein Cholesterol
The test for interaction was not significant (F = 1.06, p > 0.05). The ANOVA did
not yield a significant main effect for time, (F = 1.67, p>0.05), with means for the
exercise group being 51, 49, 46 and the means for the non-exercise group being 54, 52,
53 for baseline, 45 days and 90 days, respectively (see figure 5).

Figure 5
HDL Cholesterol over Time
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Therefore, there was no significant difference in the HDL cholesterol levels from
baseline to 45 days, from 45 days to 90 days and from baseline to 90 days in both
exercising and non-exercising groups. The ANOVA did not yield a significant main
effect for group, (F = 1.07, p>0.05), with means being 49, 53 for exercise and non
exercise, respectively (see figure 6). Therefore, there was no significant difference in
HDL cholesterol for the exercise and non-exercise groups, nor was there a significant
difference between exercise and non-exercise.
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Figure 6
HDL Cholesterol and Exercise Group
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In the present study, serum total cholesterol and low-density lipoprotein
cholesterol was significantly reduced in both exercise and non-exercising groups after
taking three months o f the dietary fiber supplement. Total serum cholesterol
concentrations in the exercise group were reduced by 7.96%, and in the non-exercise by
7.84%. Low-density lipoprotein concentrations in the exercise group were reduced by
13.3% and in the non-exercise group decreased by 10.46%. Similar reductions in total
cholesterol have been reported in other studies using insoluble fibers, such as pectin, guar
gum, psyllium, legumes, oat bran and locust bean gum. Van Horn, Liu, Parker, Emidy,
Liao, Pan, Giumetti, Hewitt and Stamler (1986) supplemented the diet o f healthy
volunteers on a low-fet diet with 4g soluble fiber from either oatmeal or oat bran. Serum
total cholesterol was reduced by 5% after 6 weeks on just a low fet diet and an additional
3% reduction after 6 more weeks after adding either oatmeal or oat bran (Van Horn et al.,
1986). Jensen, Spillar, Gates, Miler and Whitman (1993) also foimd similar findings
with patients who took a mixture o f guar gum, pectin, psyllium and locust bean gum
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three times a day and the subjects experienced a 10% reduction in serum TC and a 14%
reduction in serum LDL (Jensen et aL, 1993).
Total cholesterol and serum LDL cholesterol were lowered in both the exercise
and non-exercise groups without significantly afifecting serum HDL cholesterol levels. In
the exercise group serum HDL levels were reduced by 8.42% and 1.63% ia the non
exercise group. This was also observed by Anderson and associates (1992) who studied
44 hypercholesterolemic male and female participants. After one week baseUne period,
subjects were assigned to consume either 114g per day o f a psyllium-flake or wheat branfiake cereal ft>r 6 weeks. Fasting HDL cholesterol levels did not change significantly
during the six weeks (Anderson et al., 1992). In a similar study Anderson (1984) also
ft)und that in thirty-five hypercholesterolemic men with total cholesterol higher than 260
mg/dl who were placed in either a oat bran diet, dried bean diet or canned bean diet for
21 days. Twelve participants were placed in the oat-bran diet which the consumed
between 50 to 100 g o f oat bran daily as hot cereal or oat bran muffins. Eleven
participants were placed in the dried bean diet group, which they consumed 100 g o f navy
or pinto beans served in soup. The last twelve participants were placed in the canned
bean diet in which they consumed 120 g o f canned beans from Campbell’s Pork and
Beans. HDL cholesterol concentrations had a non-significant decrease o f 6% as for the
dried and canned beans there was a significant decrease in HDL concentrations.
In this study the effect o f the exercise on the participant’s total, low-density
lipoprotein, and high-density lipoprotein serum cholesterol levels was also of interest. It
has been well documented that individuals who engaged in regular cardiovascular
concentrations that place them at low risk for developing coronary artery disease. Studies
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demonstrating this lower risk include the results o f world class marathon runners having
exceptionally high plasma HDL cholesterol and relatively low total cholesterol, LDL
cholesterol and triglyceride concentrations. These findings indicate that individuals who
participate in regular strenuous exercise achieve increases in HDL levels helping reduce
the risk o f cardiovascular disease. Huttunen, Lansimis, Voutilainen, Ehnhohn, Hietanen,
Penttila, Siitonen and Raurama (1990) reported a significant increase in HDL cholesterol
by 19%, whereas plasma total cholesterol, LDL cholesteroL and triglyceride levels were
decreased by 10% in a group o f middle-aged men who performed aerobic exercise 3 to 4
days a week for 16 weeks.
Analysis o f data from the present study shows that participants performing regular
aerobic exercises three times a week for a duration o f 30 minutes and at an intensity o f
70% or more o f their predicted max heart rate had no greater decrease in lipid serum
concentrations then those in the non-exercising participants. As shown in figure 1 and 2
total cholesterol decreased 7.96% in the exercising group and 7.84% in the non
exercising group and LDL decreased 13.3% in the exercise group and 10.46% in the non
exercising group. HDL concentration decreased 8.42% in the exercise group and 1.63%
in the non-exercise group (see figure 3). Generally, when a person’s lipid levels are high,
regular exercise training can usually reduce high levels o f total and LDL cholesterol. The
exercise group’s lack o f response to have an even larger decrease in total and LDL
cholesterol concentrations when compared to the non exercise group might be explained
by the feet that each participant in the exercise group had been exercising for 6 months or
longer before entering the study. One might hypothesis that they may have already
lowered their cholesterol levels to the extent in which exercise can affect them Dietary
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therapy in conjunction with regular exercise is considered an essential element in therapy
o f elevated serum cholesterol levels. In this study, patients at risk for coronary heart
disease exhibited significant reductions in serum cholesterol after using Bios Life.
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CHAPTERS

SUMMARY AND CONCLUSIONS
Summary
An increase in the incidence o f coronary heart disease has lead to an increased
interest in preventive measures. Since there is a strong relationship between high fiber
diet, regular exercise and coronary heart disease, health professionals support a high fiber
diet and regular exercise as a contributing factor in reducit^ this incidence.
It has been well documented that both high levels o f total serum cholesterol and
specifically low-density lipoproteins are linked with coronary heart disease.
Epidemiological data from the Framingham Heart Study indicate that elevated total
serum cholesterol is a major coronary risk factor. Larosa and associates (1990) studied
CHD histoiy and total cholesterol in 2,282 men and 2,845 women and concluded that
there was definite evidence that high levels o f total cholesterol were associated with an
increase in the incidence o f CHD and that conversely low levels o f total cholesterol were
associated with a low incidence o f CHD (Larosa et al., 1990).
The general purpose o f dietary fiber supplementation as therapy is to reduce
elevated serum cholesterol levels. This is achieved primarily by reducing fet intake and
consuming a healthy diet, rich in fiber. Dietary therapy in conjunction with regular
exercise is considered an essential element in therapy o f elevated serum cholesterol
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(Ready, 1996). Exercise has been shown to help in the promotion o f weight reduction,
which enhances LDL cholesterol lowering, reducing triglyceride, raising HDL, reduces
blood pressure and decreasing the risk o f diabetes mellitus. Therefore, the combination
o f regular exercise and diet rich in fiber can lower total cholesterol, increase HDL,
decrease LDL and consequently reduce the risk o f CHD.
The purpose o f this study was to investigate the effects o f Bios Life, a non
prescription dietary fiber supplement, on Total and LDL cholesterol and determine
whether exercise accentuates this effect. Fifty (50) male and female subjects volunteered
to participate. Twenty-five were exercising regularly in a supervised exercise program
and the other 25 were sedentary. A 12-hour fasting blood sample was taken prior to the
study to obtain a baseline value and again at 45 and 90 days. Subjects had to have LDLC greater than 130 mg/dl to participate in the study. Both groups took 4.5 gram packets
o f Bios Life twice a day. Neither group changed their regular routine or eating habits.
Mean total cholesteroL low-density Upoproteins and high-density lipoproteins
were analyzed using a 2 (group) by 3 (time) analysis o f variance (ANOVA) procedure
with repeated measures on time. All statistical analysis was done using the SAS system.
The results o f this study showed that total cholesterol and low-density
lipoproteins concentrations decreased significantly from baseline to 90 days. This was
true whether or not the subject was in the exercise group or non-exercising group.
Conclusions
The following conclusions can be drawn from this study:
1. Exercise did not accentuate the effect o f Bios Life.
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Recommendations
The following are recommendations for future studies:
1. Since there was no significant difference between the exercise and non-exercise
groups it is suggested that the participants in the exercise group not be involved in an
exercise program prior to the study. Both groups should take the Bios Life, but the
participants in the exercise group start an exercise regimen at the beginning o f a
study.
2. Bios Life did decrease total cholesterol and LDL levels over the 90 days but not to the
same extent as some o f the other drugs like probucol, niacin, pravastin, and zocor. As
reported in the existing literature, further research over a greater amount o f time may
be needed to see if time would allow for a greater decrease in total cholesterol and
LDL levels with Bios Life users.
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PURPOSE
It has been documented that high levels of total serum cholesterol have been
linked with coronary heart disease. However, reductions in the low-density lipoprotein
fraction o f total cholesterol are linked with reduction in myocardial inferction and sudden
cardiac death. There is evidence indicating that dietary fiber can lower serum
cholesteroL Individuals consuming a diet high in fiber tend to have a lower incidence of
myocardial inferction and sudden cardiac death. This study will the effects of Bios Life 2
a dietary fiber supplement on serum IqmiHotems, and determine whether exercise
potentates this effect.

PRODUCT
The natural dietary fiber supplement consisted o f a mixture based on a patented
formula (# 4,824,672) and (# 4,883,788) titles "hfethod and C o n ^sitio n for Reducing
Serum Cholesterol’ manufoctured by Rexall Showcase International under the trade name
Bios Life Natural This patented formula consisted o f pectin, guar gum, gum arable, oat
fiber, and locust bean, gum. This product also contains various vitamins (beta carotene,
vitamin E, vitamin C, niacinamide, vitamin B-12, pyridoxine HCl, riboflavin, thiamine
HCl, biotin, and folic acid). In addition, diromium polynicotinate and selenomethionine
were added to enhance the metabolic a^>ects o f the product To improve palatability,
Stevia, a natural fiber with known natural sweet effects, was added to the product mix.

METHODS
As a volunteer for this study your LDL cholesterol level must be greater than 130
mg/dl and keep particÿating in a frmnal exercise program at least three times per week.
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You will givea 12-far. âsting blood sanq>le baseline, 30,60 and 90 days. Also at these
time periods heigln and we^ht will be taken and Bo<fy Mass Index computed. Waist
girth and hq>giith will be measured and waist to bq>ratio will be computed. Body fat
will be detomined by lnoinq)edance anafysis. A six-minute walk test will be
administered.
For the next 90 days you will mix Bios Life 2 a dietary fiber with an eight-ounce
glass of water, fruit juice or Gatomde. It will be taken 15 minutes prior to breakfrst and
dinner. Weekly questioning to monitor adherence to the fiba* statement will
administoed.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

63

U N IV E R S IT Y O F N E V A D A , L A S V E G A S
CO LLEG E OF HEALTH S C IE N C E S
DEPARTM ENT O F K IN ESIO LO G Y
EXERCISE PHYSIOLOGY
BOX 4 5 3 0 3 4
LAS VEGAS, NV 8 9 1 5 4 - 3 0 3 4

M E M O R A N D U M
DATE:

9/15/98_________________________

TO:

______ S ubjects for Cholesterol lowering study__________________

FROM:

Lawrence A. Golding. E-mail: T.AnmlHlnpfS)ani com and Lori inderiied

S U B JE C T : _____ Requirem ents for the study______________________________
The Exercise Physiology Laboratory Is about to sta rt a study on the effect o f a
non-prescription fiber preparation, which Is claim ed to reduce LDL Cholesterol.
Total cholesterol Is m ade up o f iow-denslty lipoprotein cholesterol (LDL-C) and
high density lipoprotein cholesterol (HDL-C). The popular literature refers to LDL
a s the "bad” cholesterol and th e HDL a s the "good” cholesterol.
This study will Investigate the effect of taking th is supplem ent In people w ho are
exercising and in people who are sedentary. All subjects m ust have a LDL
cholesterol of m ore than 130mg/dl.
You have been Identified a s som eone who is exercising regularly (the adult
exercise program) b u t who h a s a LDL cholesterol greater than 130mg/dl. We
would like you to volunteer to be a s u b je c t
The details of the study are a s follows:
1. The study will be 90 d ays in duration.
2. A llpid profile will be done prior to the study starting, after 45 days and again at
the end of th e study.
3. During th o se sam e 3 tim es th e following m easurem ents will be taken:
I. Percent fat by Bioimpedance. This only requires two electrodes to be
placed on your w rist and ankle. A very low-grade electric current (from a
9voK battery, w hich you will not feel) will p a ss betw een the electrodes and
im pedance will be m easured from which percent fat Is calculated. This is
done in stre e t clothes only requiring the right sh o e and sox to be removed.
II. Height and welghL
III. Waist and hip girth
hr. A Sminute walk will b e done for time.
V. Every two w eeks you will be asked to com e to the laboratory to pick up
your two week supply o f Blosllfe and return the em pty packages from the
previous two w eeks. This is the way w e docum ent th at you have taken the
Bloslife. If you m iss a dose, simply bring back th e full package and w e can

Tdcplione; (702M 9S-3766
FAX, (702)-895-4191
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record w h at you m issed. When you com e in weight will be taken and a
modified p ercen t fat through bioim pedance will be done. This modified
procedure only requires you to hold and Instrum ent in your hand,
vl. Prior to starting, you will be asked to complete a simple questionnaire
to determ ine how much fiber you are presently consuming In your normal
dally diet.
Enclosed Is an Informed c onsent form which explains the above. If you are
willing to participate please sign th e form, have your signature w itnessed
and return it in th e enclosed, self a d d ressed stam ped envelope.

Telephone; (702)-895-3766
FAX, (702)-895-4191
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TJNTV
DATE:
TO:
FROM:

RE:

May 11, 1998
Lori J. Inderiied (KIN)
M/S: 3034
' Dr. William E. Schulze
o^^'VDirector, Office of Sponsored Programs and
y Member, Biomedical Sciences Committee
UNLV Institutional Review Board
Status of Humcui Subject Protocol entitled:
"The Effect of Bios Life, a Non-prescription
Cholesterol-Lowering Substance and a Combination of
Bios Life and Exercise on Serum Lipids :“
OSP #504s0498-013b

This memorandum is official notification that the protocol for
the project referenced above has been approved by the Biomedical
Sciences Committee of the Institutional Review Board. This
approval is approved for a period of one year from the date of
this notification, and work on the project may proceed.
Should the use of human subjects described in this protocol
continue beyond a year from the date of this notification, it
will be necessary to request an extension.
If you have any questions or require any assistance, please
Marsha Green at 895-1357.

cc: L. Golding (KIN-3034)
OSP File

Office of Sponsored Programs
4505 Maryland Parkway • Box 451037 • Las Vegas, Nevada 89154-1037
(702) 895-1357 • FAX (702) 895-4242
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CONSENT TO PARTICIPATE IN RESEARCH
UNIVERSITY OF NEVADA, LAS VEGAS
EXERCISE PHYSIOLOGY LABORATORY
i

^
I
_
s

TITLE OFTHE STITDY
The effect o f Bk>s Life axid a combination o f Bios Life and exercise on total cholesterol,
serum bw density lipoprotein, and serum high density Iqx>piotein will be invest^ated.
PURPOSE
It has been weU documented that high fevels o f total serum cholesterol have been linked
with coronary heart disease. However, reductbns in the b w density lipoprotein feactbn
o f total cholesterol are linked with reductbn In myocardial inferctbn and sudden cardiac
death. There is evidence iixiicating that dietary fiber can bw er serum cholesteroL
bxlividuals consuming a diet high in fiber tend to have a bw er incidence o f nyocardial
inferctbn and sudden cardiac death. This study will mvestigate the effects o f B b s Life, a
dietary fiber stqrplement on serum lipoproteins, and determine whether exercise
potentiates this effect.

y

L

^
'
V
)
f
R

\
?

PROCEDURES
If you decide to partbipate in this Study you will report to eifirer the Exercise Pfaysbbgy
Laboratory or the Cardbvascular Center o f Southern Nevada fer an explanatbn o f the
study. A six mmute walk test will be given as well as weight arxi body percent fet taken.
Four times during the study you win report to the bbod lab fer a 12 hour festing bbod
sarr^te to be collected. There is no cost to you as a pattbq>ant fer any tests done in this
project The details o f the study areas felbwed:
Pretreatmem Period: A 12 hour fisting bbod sanyb will be taken fiom each
partbqrant to determine if they fiilfiU the cholesterol arb lipoprotein criteria. The criteria
to partbqrate is ones LDL must be 130 mg/dl or greater. Orx% 50 participants are
identified body fet and weight will be takerL A six mmute walk wUl be administered to
determine aerobb capacity.
Treatment Perbd: The group wfil be randomly divided in two grouns: The
control groiç will not be exercising and wfll remain on tfaerrcurreittdiet. The
experimental grorq) win continue, their regular exercise program at least three times per
week.
Each grotq) will be instructed to consume 4 .5 g o fB b s Life beferebreakfest and
dinner by stirring the contents o f one packet into an 8oz glass o f half water arxi halfjuice
arxi drink immediately. This will be done 15 minutes prbr to Ixeakfest and dinner
everyday fer the length o f the study. Partbipants wOl have a festing lipid panel
conqrleted 30,60 arxi 90 days later. Also weight, aerobb capacity arxi body percent fet
will be measured at 30,60 arxi 90 days.

RISKS
The risks o f taking B b s Life are m m im al. This is an non-prescriptive dietary siqrplement
administered comnaonly be cardbbgists. Efowever, using this product may result in mild
gastroirrtestinal distress, increases stool volume, Hkrrhm*, constipatbn, abdominal
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cranqnngor^ipetitesiqrpressioa Ifyou experience any ofthese side affects, please
repent to the leseardier as soon as possible and also consult your plqrsician if necessary.
BENEHTS
The benefits include a reduction in LDL-C and increase in HDL-C. The exercise group
will benefit fix>mthe physical effect o f exercise, and the value o f exercise combined with
ingestion o f Bios Life win be known.
COWFTDENTfALITY
Your particpetionm and the results o f this study wiUremamconfidentiaL On^ those
parties dhectfy related whh the coUection and analysis o f data wfll have access to your
file. Iffhe data is presented in a scientific journal or conférence you wOl be referred to
by aparticipam number not your name.
RIGHT TO REFUSE OR WITHDRAWAL
Your particpation in this sturfy^is strictfy voluntary. You nay withdraw consent or
refiise to participate at any tinae.
QUESTIONS
Any questions you have about the study it's purpose, dmagn, methodology, procedures
arxi significance will be addressed to your satisfictioa If you have additioral questions
please feel fiee to contact Lori hxlerlied or Dr. Goldirg at 895*3766 or Chetri Epstein
Director o f the Cardiac Rehabilitation program at 254-2400.
For questions regarding the r%hts o f research participants you rray contact the OfBce o f
Sponsored Programs at 895-1357.
You will be given a s%ned arxi dated copy o f this fimn fer you records.

I UNDERSTAND THE RESEARCH PROCEDURE AND HAVE DECIDED TO
VOLUNTEER AS A RESEARCH SUBJECT. I HAVE READ THE PROVIDED
INFORMATION AND ALL QUESTIONS REGARDING THE EXPERIMENT
HAVE BEEN ANSWERED TO MY SATISFACTION. I UNDERSTAND THAT I
HAVE THE RIGHT TO WITHDRAW FROM THIS STUDY AT ANY TIME
WITHOUT RECRIMINATION.

Name o f Particpant (print)

Signature

Date

Name o f Witness ^xrint)

Signature

Date
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INSTRUCTIONS OF DIETARY SURVERY
HELPFUL MEASURING GUIDE
DIETARY SURVEY
EXPLANATION OF DIETARY SURVEY
LIST OF MINERALS AND VITAMINS
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UNLV
University o f Las Vegas Nevada
Inderiied Cholesterol/Bios Life Study
Instructions on Dietary Survey

For three days you wül write down everything you eat including beverages in the first
column. In the second column you will put down the amount o f your servings. Attached
to the dietary survey there is a helping guide, this allows you to figure out the exact
serving size. The third column you will write down how you prepared the food. For
example: You baked chicken in the oven. Remember to count what you might have
marinated the chicken in and also how you coated the baking pan. The last column is for
any comments that you might want to add for the nutritionist who wül be analyzing the
survey.
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UNLV XwrÜMn Ptofnm
3 Day Food Record
(For Extrdse M r^obgy (Sulourol Study)

Xemc
Todav's Dale:
Food or Beverage

A*e: ,
Wdgta:

. Gender _
_ Heighu .
Amount
Eaten

Method Prepared
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U N IV
J u n el, 1999
Mm.
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OMTMm.'
Eneknad you «wl find report of your food inteka fin o m tha Ihraa d iys you
raoordad. Your Maka waa oomparad to toa Meal Raoonvnandad Diatwy
adowanoaa or fha appropdato dMary goal ounamdy laoommandad for toaf
mitriant Thie intaka indicatoa only thanufifanli in fha feoda you ala for fha fhraa
daya you raoordad and doaa not induda any vitamin, mtoaral or diataiy ftoar
auMamanta that you may taka
We have tiighiighted the nutrtenta In your diet whioh are tMowr
raoommandad amounta. A let of aalactod vitamin and mirwrai food aouroaa la
aiao andoaad for your knowtadga.
If you have any queationa regarding your reauka. pleoae c a l Dr. Suaan L
Maaoham at 702-896-1169 or laava a maaaaga at 702-99S-4328
Sinoaraly,

Suaan L . Maacham. PhD .. R.D
Aaaiaiant Profaaaor

DrammrmorMLmke
490SMayl»idPlMlaMV*BOK48»t8 • U»V<QW. Nawrdr 9919*0019

1700 am neo# FAX(702) 986-1907
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May 28,1999

Serviig Size: 2471.53 g (87.18 oz.)
ScMes:
3
Cost
—
% comparisoD to : >

MuM-Columm

Basic Compononts
VhaamAHE
928J3RE 116%
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1466.19
70% A-CtiMeBaid
220.04RE
Fhnride
PMcm
4 3 j6 g
74% A-ReHmri
SS.S9RE
Caiboi^dnles
230.27g
S2% TlmmmBl
1.07mg 102% Ino
DietmyFiber
15.76 g 75%
Megnomm
SohM eFta
3.95 g
1
11' i|iirillF niiW lkP 71lï Mangasem
InSoiobieFiber
6.74g
Sagv-ToOl
147.41g
P b a jto »
Moooacdurides
18.41 g
V|
DiaodBiides
15J8g
OtherCubs
55A )g
g g g B W B @ S S g |B K i^ |%

VimmmC

Water
VitHnins

0.06 g

534% Sdenmm

14J6mg 96%
256.44 mg 92%
4.25 mg 121%
533.81 mg

67%

T3T$0d ^

80%

_

^UMlÊDaS^^SIBSSÊfSmH Sodmm
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5.23mg
^SB SS^^Sm m sSÊ SSÊ Êm s^m
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Bom

lS3J3mcg 102% OOMTFalS

onegi3FmtyAddi

0.10 s ,

2014.45 g
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M in e r a ls
Calcium
Milk, cheese, related dairy products, dark green leafy vegetables, legumes (dried beans, peas), some tofu,
almonds

Chromium
Mushrooms, prunes, nuts, asparagus, meat, organ meat (heart, kidney. Ever), whole grains, cheese
Copper
Seafood, shellfish, organ meat (heart. Iddney. liver), whole grains, nuts, seeds, vegetables, water from copper

pipes
Iodine
Iodized salt, some seafood, plant & animal products from fertilizers and feed, dairy products from feed
additives and disinfectants, breads through the iodates In dough conditioners

Iron
Lean meats, fish, poultry, organ meat (heart, kidney, liver), legumes, nuts, seeds, whole grains, green leafy
vegetables

Magnesium
Whole grains, legumes, nuts, seeds, chocolate, dark green vegetables, banamas
Manganese
Whole grains, cereal products, tea, fruits, vegetatiles
P h o sp h o ru s
Protein-rich foods (espedally animal protein), cereal grains, milk, milk products, meat
Potassium
Fresh fruits: peaches, pears, cantaloupe; fresh vegetables: winter squash, potatoes, spinach, legumes, yogurt
Selenium
Seafood, meats, eggs, whole grains, brazil nuts, legumes
Sodium
Sodium Intake may be reduced by eating more whole grains, fresh fruits and vegetables
Zinc
Seafood, meats, whole grains, legumes. Shellfish are higher in zinc concentration than white fish, and darker
poultry meat has more than light m eat

Dietary Jiber

•

fresh fruits 4 vegetables, legumes, nuts, seeds, vhole grains, tvhale grain products
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'Vitamins
vitamin A
From plant sources (carolenoids): broccoli, swiss chard, kale, spinach, romaine lettuce, endive, carrots, sweet
potatoes, winter squash, apricots, peaches, cantaloupes, papayas (yellow/orange vegetables and fruits). From
retinot (animal sources): liver, fish Ever oils, margarine, milk, milk products, butter, eggs

B1- Thiamin
Whole grains, legumes (beans and peas), seeds, pork, organ meats (heart, kidney. Ever), brewer’s yeast, breads
made with enriched white wheat flour, fortified cereals
B2-RIboflavIn
Dairy products, eggs, whole grains, fortified cereals, baked goods made with enriched white wheat flour,
broccoli, asparagus, tumlp greens, spinach. Ever
B3 - Niacin
Meat, fish, poultry, breads made with enriched flour, fortified cereals, mushrooms, baked potatoes, peanuts
Vitamin B6
Chicken, fish, pork, eggs. Ever, (whole grains) brown rice. oats, whole wheat products, soyt)eans. peanuts,
avocados, bananas
Vitamin B12
Meats, dairy products, eggs
Biotin
Kidney, Ever, egg yoik, soy flour, cereal grains, yeast
Vitamin C
Fresh fruits &vegetables, espedatty dtrus fruits, broccoli, cauliflower, sweet & hot peppers, strawberries
Vitamin D
Fortified processed cow’s milk and Infant formula, egg yolks, butter. Ever, some fatty fish, fortified margarine,
sunshine
Vitamin E
Whole grains, vegetable oils, margarine, salad dressings, foods high in unsaturated fats. nuts, seeds, poultry,
fish, eggs
Folacln/Foiate
Fresh, green, leafy vegetables. Ever, legumes, oranges, peanuts, sunllower seeds, whole grains
Vitamin K
Green leafy vegetables, members of the cabbage family, mUk. soybean oil, egg yolks
Pantothenic Acid
Whole grains, legumes, some vegetables and fniits, organ meats (heart, kidney. Ever), yeast, egg yolk '
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Baseline

U M EV
INDERLIED CHOLESTEROL/BIOSLIFE STUDY
DATA SHEET
TESTER_________________

DATE

SUBJECT

SUBJECT #

TESTING LOCATION

SEX

HEIGHT__________________INS.

M

F

W EIGHT_____________LBS.

BMI_______________
BOP GIRTH________________ INS-

W AIST GIRTH________________INS.

W A IST/m P RATIO___________________
BIOIMPEDANCE_______________ OHM S.
BLOOD PANEL:
TOTAL____________ mg/dl
LDL_____________ mg/dl

______________% FAT

HDL__________mg/dl
HDL/RATTO__________ mg/dl

TRIGLYCERIDES___________m g/dl
6-MINUTE W A L K _______________ # LAPS
NUMBER OF PACKETS OF BIOSLIFE RETURNED
FULL
EMPTY
DATE TEST STARTED
NEXT SCHEDULED APPOINTM ENT.
COIHMENTS:

C o lle g e o f H e a lth S c ie n c e s
D e p a r tm e n t o f K in esio lo g y
4 5 0 5 M a ry lan d P a rk w a y • B o x 4 5 3 0 3 4 • L a s V e g a s, N e v a d a 8 9 1 5 4 - 3 0 3 4
(702) 8 9 5 - 0 9 9 6 • FAX (7 0 2 ) 8 9 5 -1 5 0 0
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45 Days

I7 N T V

INDERLIED CHOLESTEROL/BIOSLIFE STUDY
DATA SHEET
TESTER_______________

DATE

SUBJECT

SUBJECT #

TESTING LOCATION

SEX

HŒTGHT__________________ INS.

M

F

W EIGHT_____________ LBS.

BM I_______________
m P GIRTH

INS.

W AIST GIRTH________________ INS.

WAIST/BŒP RATIO___________________
BIOIMPEDANCE________________O H M S.
BLOOD PANEL:
TOTAL_____________ mg/dl
LDL

m g/dl

______________% FAT

HDL__________mg/dl
HDL/RATIO___________m g/dl

TRIGLYCERIDES___________m g/dl
6-MINUTE W A L K ________________# LAPS
NUMBER OF PACKETS OF BIOSLIFE RETURNED
EMPTY______________
FULL ___________
DATE TEST STARTED
NEXT SCHEDULED A PPO INTM ENT.
COMMENTS:

C o lle g e o f H e a lth S c ie n c e s
D e p a r t m e n t o f K in esio lo g y
4 5 0 5 M a ry la n d P a rk w a y • B o x 4 5 3 0 3 4 • L as V e g a s , N e v a d a 8 9 1 5 4 - 3 0 3 4
(702) 8 9 5 - 0 9 9 6 • FAX (702) 8 9 5 -1 5 0 0
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90 Days

IJN T V
INDERLIED CHOLESTEROL/BIOSLIFE STUDY
DATA SHEET
TESTER

DATE

SUBJECT

SUBJECT #

TESTING LOCATION________

SEX

HEIGHT__________________ INS.

M

W EIGHT

F
LBS.

BM I
HIP GIRTH

INS.

INS.

W AIST GIRTH

W AIST/HIP RATIO
BIOIMPEDANCE

OHM S.

BLOOD PANEL:
TOTAL
LDL

mg/dJ
m g/dl

TRIGLYCERIDES
6-M INUTE W ALK

% FAT

EQ>L__________mg/dl
EDDL/RATTO___________m g/dl

_______m g/dl
#L A P S

NUM BER OF PACKETS OF BIOSLIFE RETURNED
FULL
EMPTY
DATE TEST STARTED
NEXT SCHEDULED APPOINTM ENT
COMMENTS:

C o lle g e o f H e a lth S c ie n c e s
D e p a r t m e n t o f K in esio lo g y
4 5 0 5 M a ry la n d P a r k w a y • B o x 4 5 3 0 3 4 • L a s V e g a s , N e v a d a 8 9 1 5 4 - 3 0 3 4
(7 0 2 ) 8 9 5 - 0 9 9 6 • FAX (7 0 2 ) 8 9 5 -1 5 0 0
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Exercise Group
Baseline
45 Davs
284
Subject 1
270
196
Subject 2
196
190
Subject 3
186
204
Subject 4
203
Subject 5
316
239
246
250
Subject 6
230
Subject 7
249
272
Subject 8
279
Subject 9
197
225
227
Subject 10
227
Subject 11
218
211
220
Subject 12
246
Subject 13
209
188
Subject 14
230
209
Subject 15
287
378
218
Subject 16
217
Subject 17
210
209
246
230
Subject 18
230
Subject 19
230
288
270
Subject 20
Subject 21
200
213
Subject 22
222
177
Subject 23
269
279
222
200
Subject 24
313
Subject 25
359
242
233.36
Mean
41.560197 44.598094
Std. Dev.
Std. Error 8 J 120395 8.9196188

Raw Data Total Cholesterol
Non-Exercise Group
90 Davs
250
180
180
200
277
248
225
273
199
228
190
235
183
200
293
200
200
200
200
270
200
200
280
205
253
222.76
35.18910816
7.037821633

Subject 26
Subject 27
Subject 28
Subject 29
Subject 30
Subject 31
Subject 32
Subject 33
Subject 34
Subject 35
Subject 36
Subject 37
Subject 38
Subject 39
Subject 40
Subject 41
Subject 42
Subject 43
Subject 44
Subject 45
Subject 46
Subject 47
Subject 48
Subject 49
Subject 50
Mean
Std. Dev.
Std. Error

90 Da
Baseline
45 Davs
228
237
240
200
200
205
200
200
200
210
240
260
200
210
220
253
313
359
230
255
283
240
270
280
190
221
211
250
240
250
200
210
210
237
240
228
260
265
265
244
250
264
212
246
234
212
236
246
246
246
246
280
290
290
210
210
210
214
200
222
237
237
240
205
205
205
255
255
283
250
270
284
210
210
210
226.92
237.84
246.2
36.924472 29.762504 23.891979
7.3848945 5.9525009 4.7783958
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Exercise Group

Subject 1
Subject 2
Subject 3
Subject 4
Subject 5
Subject 6
Subject 7
Subject 8
Subject 9
Subject 10
Subject 11
Subject 12
Subject 13
Subject 14
Subject 15
Subject 16
Subject 17
Subject 18
Subject 19
Subject 20
Subject 21
Subject 22
Subject 23
Subject 24
Subject 25
Mean
Std. Dev.
Std. Error

Raw Data LDL Cholesterol
Non-Exercise Group

Baseline
45 Davs
90 Davs
206
197
160
133
133
120
132
130
125
141
139
130
189
165
140
142
173
149
162
150
140
177
173
150
142
140
173
154
154
172
154
150
130
143
113
120
155
117
136
124
139
112
296
211
219
134
133
120
134
136
129
136
140
129
140
140
130
161
171
161
162
172
146
126
140
123
155
145
170
174
164
131
196
236
139
154.48
139.64
161.2
27.971712 36.766289 20.605177
5.5943424 7.3532578 4.1210355

Subject 26
Subject 27
Subject 28
Subject 29
Subject 30
Subject 31
Subject 32
Subject 33
Subject 34
Subject 35
Subject 36
Subject 37
Subject 38
Subject 39
Subject 40
Subject 41
Subject 42
Subject 43
Subject 44
Subject 45
Subject 46
Subject 47
Subject 48
Subject 49
Subject 50
Mean
Std. Dev.
Std. Error

90 Davs
Baseline
45 Davs
137
129
138
130
132
140
130
130
130
130
180
170
126
146
136
139
236
196
114
114
158
140
160
160
124
120
131
135
140
135
141
130
140
137
138
129
175
180
180
130
139
139
136
140
143
146
131
149
138
138
138
154
158
158
141
141
140
149
138
137
129
138
129
132
132
132
114
158
114
160
206
197
141
141
140
135.6
151.44
144.24
13.400871
25.270338 21.6781
5.0540677 4.3356199 2.6801741
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Exercise Group

Subject 1
Subject 2
Subject 3
Subject 4
Subject 5
Subject 6
Subject 7
Subject 8
Subject 9
Subject 10
Subject 11
Subject 12
Subject 13
Subject 14
Subject 15
Subject 16
Subject 17
Subject 18
Subject 19
Subject 20
Subject 21
Subject 22
Subject 23
Subject 24
Subject 25
Mean
Std. Dev.
Std. Error

Raw Data HDL Cholesterol
Non-Exercise Group

45 Davs
Baseline
90 Davs
54
Subject 26
58
50
Subject 27
49
46
49
20
54
Subject 28
25
Subject 29
48
51
30
66
Subject 30
53
56
61
71
Subject 31
61
54
Subject 32
64
64
48
44
Subject 33
62
27
Subject 34
45
23
Subject 35
31
36
31
Subject 36
30
31
31
84
Subject 37
82
58
Subject 38
23
29
31
Subject 39
50
59
51
60
Subject
40
43
39
Subject
41
45
50
47
Subject 42
58
51
58
45
Subject 43
45
45
Subject 44
65
50
65
60
Subject 45
70
60
Subject 46
54
50
46
Subject 47
55
31
29
94
Subject 48
60
86
26
Subject 49
28
27
55
Subject 50
56
59
49.84
Mean
51.28
46.96
17.145262 17.747488 11.890052 Std. Dev.
3.4290523 3.5494976 2.3780104 Std. Error

Baseline
60
54
54
60
54
56
64
56
54
54
54
82
34
61
32
39
60
64
50
22
60
54
64
60
48
54
12.086494
2.4172988

45 Davs
60
56
54
60
54
55
63
56
43
54
52
60
34
61
34
39
60
64
50
19
60
54
63
60
40
52.2
11.25833
2.251666
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90 Davs
82
50
54
48
50
59
50
50
54
50
50
60
29
61
36
41
60
62
50
27
60
54
63
82
46
53.12
12.80403(
2.5608072

APPENDIX E

PHYSICAL CHARACTERISTICS
BODY COMPOSTION TABLES
BODY MASS INDEX
WAIST/HIP CIRCUMFERENCE
W AIST/mP RATIO PERCENTILE FOR HEART DISEASE
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D
■CD
O
Q.
C

gQ.
■CD
D
Physical Characteristics of Participants

C/)
C/)

Exercise Group
Sex

■8D

CD

3.
3"
CD
D
■CD
O
Q.
C

aO
3
"O
o
CD

Q.

■CD
D
C/)
C/)

Subject 1
Male
Subject 2
Female
Subject 3
Male
Subject 4
Male
Subject 5
Female
Subject 6
Male
Subject 7
Female
Subject 8
Male
Subject 9
Male
Subject 10 Female
Subject 11 Female
Subject 12
Male
Subject 13
Male
Subject 14 Female
Subject 15
Male
Subject 16
Male
Subject 17
Male
Subject 18
Male
Subject 19 Female
Subject 20 Female
Subject 21 Female
Subject 22
Male
Subject 23 Female
Subject 24
Male
Subject 25
Male
Mean
Standard Dev,
Standard Error

Age
Years

Height
Inches

Weight
Pounds

BMI

Waist to Hip Ratio

Bioimpedance
Ohms

% Fat

6-Minute W alk Test

50
32
58
53
50
36
63
50
59
59
53
56
59
47
47
64
54
60
52
48
50
59
30
65
45
51.96
9.18
1.84

70
63
69
73
68
71
71
73
71
64
63
72
69
64
70
68
61
69
67
66
60
68
67
72
71
68
3.71
0.74

215
138
170
250
163
156
186
246
178
120
166
200
177
171
188
131
153
190
155
162
132
156
142
257
166
174.72
36.25
7.25

31
24.5
25
31
24
22
26
33
25
21
29
28
26
29
27
20
29
28
23
26
26
23
22
30
23
26.06
3.41
0.68

0.8
0.8
0.9
0.6
0.75
0.8
0.75
1
0.9
0.8
0.9
0.8
0.8
0.75
0.85
1.1
0.8
0.8
0.8
0.9
0.9
0.9
0.8
1.1
0.75
0.842
0.11
0.02

400
478
486
486
557
477
586
403
462
400
586
496
496
483
451
531
464
470
581
580
581
467
389
486
478
490.96
60.47
12.09

21.3
24.2
19.7
36.8
29.7
13.9
33.1
23
17.6
21
37.8
29
27
32.7
19.8
13.8
23.8
24.2
30.5
31
21
16.1
16.1
36
16.1
24.608
7.37
1.47

7 laps
8 laps
8 laps
8 laps
6 laps
8 laps
6 laps
6 laps
7 laps
5 laps
6 laps
7 laps
7 laps
6 laps
6 laps
6 laps
6 laps
6 laps
7 laps
6 laps
6 laps
8 laps
7 laps
5 laps
9 laps
6.68
1.03
0.21

D
■CD
O
Q.
C

gQ.
■CD
D
C/)
C/)

Physical Characteristics of Participants
Non-Exercise Group
Sex

■8D

33"
CD
D
■CD
O
Q.
C

aO
3
"O
O
CD
Q.

■CD
D
C/)
C/)

Subject 26 Female
Subject 27
Male
Subject 28 Female
Subject 29
Male
Subject 30
Male
Subject 31 Female
Subject 32 Female
Subject 33 Female
Subject 34 Female
Subject 35
Male
Subject 36
Male
Subject 37
Male
Subject 38 Female
Subject 39
Male
Subject 40 Female
Subject 41 Female
Subject 42
Male
Subject 43 Female
Subject 44 Female
Subject 45
Male
Subject 46 Female
Subject 47
Male
Subject 48 Female
Subject 49 Female
Subject 50
Male
Mean
Standard Dev.
Standard Error

Age
Years

Height
Inches

Weight
Pounds

BMI

W aist to Hip Ratio

Bioimpedance
Ohms

% Fat

6-Minute W alk Test

57
56
60
59
50
46
40
30
60
56
51
40
48
57
36
38
45
55
39
36
57
52
44
30
59
48.04
9.69
1.94

67
62
70
68
72
60
62
70
70
74
66
62
68
72
64
62
70
61
58
67
64
67
64
67
68
66.2
4.16
0.83

141
131
180
140
205
120
130
221
174
250
140
140
131
186
140
146
200
205
150
166
154
283
126
142
156
166.28
41.28
8.26

22
24
26
21
28
23
24
30
25
30
24
25
35
25
24
27
29
35
30
25
26
40
21
22
23
26.56
4.71
0.94

0.8
0.8
1
0.8
0.9
1
1
1.1
1.1
1.1
0.8
0.9
0.9
0.9
0.7
0.9
1
1
I
0.9
0.7
1.2
0.7
0.8
0.9
0.916
0.13
0.03

648
648
423
477
486
300
400
535
386
586
486
424
648
500
480
464
500
486
486
423
646
537
648
389
467
498.92
94.86
18.97

28.8
28.8
16.1
13.9
28
18
23
15
17.1
27
23
12
28.6
26
25
28.6
24.6
31.1
26.7
16.1
28
34.4
28.8
16.1
16.1
23.232
6.36
1.27

7 laps
6 laps
8 laps
7 laps
6 laps
6 laps
7 laps
7 laps
6 laps
6 laps
6 laps
4 laps
5 laps
5 laps
8 laps
4 laps
7 laps
4 laps
7 laps
8 laps
7 laps
7 laps
8 laps
7 laps
8 laps
6.44
1.26
0.25

88
BODY COMPOSmON (% BODY FAT) FOR MEN*
Age
% ile
20-29
30-39
4 0 -4 9
50-59
60+
52.4
99
<6.6
S5.2
<8.8
57.7
11.4
5.2
95
9.1
12.9
13.1 S
7.1
13.6
90
11.3
15.3
15.3
12.7
65
8.3
15.1
16.9
17.2
9.4
80
16.3
13.9
18.4 E
17.9
75
10.6
17.3
14.9
19.0
19.3
70
11.8
18.1
19.8
15.9
20.3
65
12.9
18.8
16.6
20.6
21.1
60
14.1
19.6
17.5
21.3
22.0 G
55
15.0
18.2
20.3
22.1
22.6
50
15.9
22.7
19.0
21.1
23.5
23.4
45
16.8
19.7
21.8
24.3
40
17.4
24.1
25.0 F
22.5
20.5
35
21.4
24.9
18.3
23.3
25.9
30
25.7
24.1
19.5
22.3
26.7
25
20.7
26.6
23.2
25.0
27.6
22.4
20
27.5
26.1
24.2
28.5 P
IS
27.3
23.9
28.8
29.7
25.5
10
28.9
25.9
27.3
30.3
31.2
5
32.4
29.1
31.5
33.4 VP
29.9
1
237.4
236.4
238.1
235.6
241.3
N=
5724
1342
984
5611
3275
TOTAL N = 16936
'Data provided by (he Instituie lor Aerobics Research, Dallas. TX (1994). S, superior E. excellent; G.
good; F. lair: P. poor VP. very poor.
BODY COMPOSITION (% BODY FAT) FOR WOMEN*
Age

•/• ile 20-29
4 0 -4 9
50-59
30-39
60+
<15.4
55.4
99
<11.6
57.3
511.6
13.4
95
10.8
16.8 S
16.1
18.8
90
18.5
21.1
14.5
21.6
15.5
85
20.3
16.0
23.6
23.5
16.9
80
17.1
21.3
25.1 E
18.0
25.0
22.4
26.7
75
18.2
25.8
19.1
70
23.5
19.0
20.0
26.6
27.5
27.4
65
19.8
24.3
28.5
20.8
60
20.6
24.9
28.5
29.3 G
21.6
55
22.4
25.5
29.2
29.9
21.3
26.4
50
22.1
30.1
30.9
23.1
45
22-7
27.3
31.8
24.0
30.8
40
32.5 F
23.7
28.1
31.6
24.9
35
24.4
29.0
33.0
26.0
32.6
30
25.4
30.1
33.5
34.3
27.0
25
31.1
34.3
35.5
26.6
28.1
27.7
20
32-1
35.6
36.6 P
29.3
15
33.3
36.6
38.0
29.8
31.0
35.0
39.3
10
37.9
32.1
32.8
35.4
37.8
40.5 VP
5
35.7
39.6
1
245.5
240.5
250.8
&47.0
240.0
1175
708
250
N=
638
1336
TOTAL N = 4107
'Data provided by the Institute for Aerobics Research, Dallas. TX (1994). S. superior E. excellent- o.
good; F. fair P. poor VP, very poor.
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■o
o

Q.

c
8Q.
■CoD

BODY MASS INDEX

C/)

o'

3
O

:

19

20

1 21

1 91
1 94
1 97

96
99

i 100 j 105
1 10^ I 109

102

112 ! 11*
, 1 " 1 116 I 122
' 115 ' 120
126
1 11* i 124 ! 130
122
128
134
1 126 1 132 i 138
130
136
142

1 22

23

24

BODY M ittS INDEX
j 25 I 26 1 27

28

29

'

30

35

40

1

CD

8
■
vD
<
c5'

58
59

o

60

3

61

106

62

1 100
1 104

3.
3"

63

1 107

113

CD

64

j

110

116

114

120

j 118
121
1 125

124

■CoD
O
Q.
C
aO
3
TD
O
CD

Q.

TCD
D
C/)

o'
3

65
66
67
68
69
70
71
73
74
75
76

j 128
132
1 136
140
1
144
1 148
152
i 156

Less than 20
Weight gain
may be advisabie

109

i 110
114

, 107 j

W elfltitdbs)
115 j 119
124 1 129
119
124
128 1 133
123 I 128
133
138
127 , 132
137 I 143

1
134
138
148

138 j 143 1 167
143 ! 148
173
148 I 153 1 179
153
158 . 185
158 j 164

143

142 1 147
146
152

153
158

191
163 I 169 1 197

211
218
225 j

151

1 157

163

169

174

204

232 I

144

156

168

174
179
185
190
196
202
208
213
219

1 180
186
1 191
197
1 203
207
* 215
I M l
227

1 210
216
1 223
230

240 I
247 1

! 236
, 243
* 250
j 258
I
265

270 1
278 '
286 j
294

1

134 1 140 ! 146
138 i 144
1
142 ' 149
155
153
i 100
‘•^6 i
150
157
165
154 I 162 i 169
159
166
174
155 : 163 ' 171 ! 179

162
161
167
166 , 172
171 ' 177

173
178
184

176
182
181
188
186 1 193
191 I 199
197 1 204
202
210

189
195
200
206
212
218

225

160
164

192
200
197 1 205

208
213

' 216
221

224
230

232
240
279
238 ; 246 > 287

168 1 176
172
180 I

184
189

204

131
136
135 1 141
140
145
150
148
155
153 I 159
158
164
162 ' 169
167 , 174
172
179
177 j 184
182
189
186 1 194

127 '
131 }
135
139 1
143
147
151

191
198

20 -2 5
Acceptable range for most people but

Escalating

potential heaith probiems with weight gain

Health risks

26 to 27

233 j 272

zw j
262

302 1
31,

,

319 j
328

Higher than 27
Dramatic risk of health problems

90

180

70

170

60

160
30

60
150

80

LU

90

WHR

LU

140

lU

0.6
LL

100

0.7

LU
U.

130
50

0.8
110

0.9

120

120

110

130

100

140

90

150

80

=1— 40

30

60

cm

cm

Reprinted from: Bray GA and Gray DS: Obesity. Part 1—Pathogenesis. Western
Western J
M ed 149:429-441. 1988.
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MEN
1.10-1
Very High RUc

loih
o
M

1.0 -

30th
Uoderat* Risk

IS 09-^

70th

I

f t
Low Risk

0.8
A
^

0.7

0.6 —
20-29

30-39

I
40-49

— r
50-59

60-69

Age (yr)
WOMEN

Very High Risk

msim
c £

30ttl

0.8

20-29

30-39

40-49
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